| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | TRIO PCP2 PLEKHG1 RIN2 HERC1 DNMBP ARHGEF19 PLEKHG7 ITSN1 MADD PLEKHG3 | 3.36e-05 | 231 | 209 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TRIO PCP2 ADGRV1 EZHIP PPP1R26 PLEKHG1 BMP2 GPR158 RIN2 HERC1 BSN DNMBP RECK ARHGEF19 TBC1D15 TRIB2 ARHGAP23 PLEKHG7 ITSN1 APC PPP4R4 MADD SPINT2 PLEKHG3 CD40LG RIMS1 MARK2 NRG3 RUBCN USP6NL | 1.78e-04 | 1418 | 209 | 30 | GO:0030234 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAPT BCL7B SYNPO ADGRV1 STIM1 PTPN4 TTBK1 SVIL CGN KCNQ2 KIF2A MTUS2 PSRC1 WIPF1 APC TRIOBP INO80 SHROOM2 EML3 TTLL7 SMTN INF2 PLEKHG3 LIMCH1 MARK2 | 2.20e-04 | 1099 | 209 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TRIO PCP2 PLEKHG1 RIN2 HERC1 DNMBP ARHGEF19 TBC1D15 ARHGAP23 PLEKHG7 ITSN1 MADD PLEKHG3 RIMS1 USP6NL | 3.06e-04 | 507 | 209 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TRIO PCP2 PLEKHG1 RIN2 HERC1 DNMBP ARHGEF19 TBC1D15 ARHGAP23 PLEKHG7 ITSN1 MADD PLEKHG3 RIMS1 USP6NL | 3.06e-04 | 507 | 209 | 15 | GO:0030695 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | METTL3 BCL7B CUL7 BAP1 SPDL1 BMP2 ARID1B TTBK1 HECW2 SVIL NABP2 PKD1 UHRF2 PSRC1 TBX1 EP400 TTC28 DTL APC PUM2 INO80 TEX14 EML3 MADD YEATS2 LATS2 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 MEIOSIN CEP131 CDC5L | 1.03e-07 | 1256 | 206 | 34 | GO:0051726 |
| GeneOntologyBiologicalProcess | cell junction organization | MAPT SYNPO NPHP4 CNTN6 GRHL1 GPR158 CGN BSN CX3CL1 ADGRL3 CACNA1A SORBS2 PCDHGC4 DSCAM DOK7 ITSN1 APC NRG2 IRX3 SHROOM2 SHISA7 TJP1 EIF4G1 CHRD LIMCH1 MARK2 NRG3 IGSF21 PCDHGC3 | 1.42e-07 | 974 | 206 | 29 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MAPT BCL7B SYNPO CUL7 SPDL1 ARID1B SYNJ1 HECW2 SVIL NABP2 PKD1 CX3CL1 PSRC1 CACNA1B ARHGEF19 TBC1D15 APC TRIOBP INO80 TEX14 SHROOM2 EML3 VPS13D INF2 TJP1 HASPIN KANK4 DYNC1LI1 MEIOSIN LIMCH1 RIMS1 MARK2 RUBCN USP6NL | 4.81e-07 | 1342 | 206 | 34 | GO:0033043 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | BCL7B SPDL1 ARID1B HECW2 KIF2A NIPBL PSRC1 APC INO80 TEX14 EML3 HASPIN DYNC1LI1 | 1.76e-06 | 254 | 206 | 13 | GO:0000819 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | BCL7B CUL7 SPDL1 ARID1B HECW2 SVIL NABP2 PKD1 PSRC1 TBX1 DTL APC PUM2 INO80 TEX14 EML3 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 MEIOSIN CEP131 CDC5L | 4.18e-06 | 845 | 206 | 24 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 4.99e-06 | 95 | 206 | 8 | GO:0030071 | |
| GeneOntologyBiologicalProcess | synapse organization | MAPT SYNPO CNTN6 GPR158 BSN CX3CL1 ADGRL3 CACNA1A SORBS2 PCDHGC4 DSCAM DOK7 ITSN1 NRG2 SHISA7 EIF4G1 CHRD MARK2 NRG3 IGSF21 PCDHGC3 | 5.48e-06 | 685 | 206 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 6.30e-06 | 98 | 206 | 8 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 7.32e-06 | 100 | 206 | 8 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 9.12e-06 | 103 | 206 | 8 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 1.11e-05 | 139 | 206 | 9 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.58e-05 | 111 | 206 | 8 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | BCL7B SPDL1 ARID1B HECW2 NABP2 PKD1 TBX1 DTL APC INO80 TEX14 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 CDC5L | 1.80e-05 | 516 | 206 | 17 | GO:1901987 |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.96e-05 | 83 | 206 | 7 | GO:0048168 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | BCL7B SPDL1 ARID1B HECW2 NABP2 PKD1 DTL APC INO80 TEX14 EIF4G1 HASPIN DYNC1LI1 ANKRD17 | 5.57e-05 | 402 | 206 | 14 | GO:1901990 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | SPDL1 KIF2A NIPBL PSRC1 APC INO80 TEX14 EML3 HASPIN DYNC1LI1 | 5.63e-05 | 212 | 206 | 10 | GO:0000070 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | BCL7B SPDL1 ARID1B HECW2 NABP2 PKD1 TBX1 DTL APC INO80 TEX14 LATS2 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 CDC5L | 6.19e-05 | 627 | 206 | 18 | GO:0044770 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | BCL7B SPDL1 ARID1B HECW2 KIF2A NIPBL PSRC1 APC INO80 TEX14 EML3 HASPIN DYNC1LI1 | 6.39e-05 | 356 | 206 | 13 | GO:0098813 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | MAPT BCL7B SPDL1 ARID1B HECW2 NABP2 APC INO80 TEX14 HASPIN DYNC1LI1 | 7.89e-05 | 266 | 206 | 11 | GO:0033044 |
| GeneOntologyBiologicalProcess | regulation of calcium-independent cell-cell adhesion | 9.93e-05 | 2 | 206 | 2 | GO:0051040 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | BCL7B CUL7 SPDL1 ARID1B HECW2 NABP2 PKD1 TTC28 DTL APC INO80 TEX14 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 | 1.03e-04 | 594 | 206 | 17 | GO:0007346 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | TRIO MAPT SYNPO GPR158 KMT2A KCNQ2 BSN CX3CL1 CACNA1A CACNA1B GRIN2C SHISA7 GRIP1 SLC4A10 CHRD RIMS1 NRG3 IGSF21 | 1.25e-04 | 663 | 206 | 18 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | TRIO MAPT SYNPO GPR158 KMT2A KCNQ2 BSN CX3CL1 CACNA1A CACNA1B GRIN2C SHISA7 GRIP1 SLC4A10 CHRD RIMS1 NRG3 IGSF21 | 1.27e-04 | 664 | 206 | 18 | GO:0099177 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | BCL7B CUL7 SPDL1 ARID1B HECW2 NABP2 PKD1 KIF2A NIPBL PSRC1 DTL APC INO80 TEX14 EML3 LATS2 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 | 1.36e-04 | 854 | 206 | 21 | GO:1903047 |
| GeneOntologyBiologicalProcess | negative regulation of hormone biosynthetic process | 1.53e-04 | 11 | 206 | 3 | GO:0032353 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly checkpoint signaling | 1.53e-04 | 51 | 206 | 5 | GO:0007094 | |
| GeneOntologyBiologicalProcess | spindle assembly checkpoint signaling | 1.53e-04 | 51 | 206 | 5 | GO:0071173 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic metaphase/anaphase transition | 1.84e-04 | 53 | 206 | 5 | GO:0045841 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid segregation | 1.84e-04 | 53 | 206 | 5 | GO:0033048 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid segregation | 1.84e-04 | 53 | 206 | 5 | GO:0033046 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic sister chromatid separation | 1.84e-04 | 53 | 206 | 5 | GO:2000816 | |
| GeneOntologyBiologicalProcess | mitotic spindle checkpoint signaling | 1.84e-04 | 53 | 206 | 5 | GO:0071174 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | MAPT SYNPO KMT2A KCNQ2 CX3CL1 GRIN2C SHISA7 GRIP1 SLC4A10 CHRD RIMS1 | 1.85e-04 | 293 | 206 | 11 | GO:0048167 |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | BCL7B SPDL1 ARID1B HECW2 NABP2 PKD1 DTL APC INO80 TEX14 LATS2 EIF4G1 HASPIN DYNC1LI1 ANKRD17 | 1.94e-04 | 509 | 206 | 15 | GO:0044772 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | BCL7B CUL7 BAP1 SPDL1 ARID1B HECW2 NABP2 PKD1 KIF2A NIPBL PSRC1 TTC28 DTL APC INO80 TEX14 EML3 LATS2 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 | 2.12e-04 | 1014 | 206 | 23 | GO:0000278 |
| GeneOntologyBiologicalProcess | negative regulation of metaphase/anaphase transition of cell cycle | 2.19e-04 | 55 | 206 | 5 | GO:1902100 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome separation | 2.19e-04 | 55 | 206 | 5 | GO:1905819 | |
| GeneOntologyBiologicalProcess | cell division | POGZ CUL7 SPDL1 SVIL FGF3 MLLT3 KIF2A PSRC1 TTC28 AKNA APC TRIOBP INO80 TEX14 EML3 YEATS2 LATS2 DYNC1LI1 | 2.31e-04 | 697 | 206 | 18 | GO:0051301 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 2.39e-04 | 163 | 206 | 8 | GO:0007093 | |
| GeneOntologyBiologicalProcess | cell cycle process | BCL7B POGZ CUL7 SPDL1 ARID1B HECW2 SVIL NABP2 PKD1 KIF2A NIPBL PSRC1 TBX1 ZNF541 DTL APC PUM2 INO80 TEX14 EML3 LATS2 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 MEIOSIN CEP131 CDC5L | 2.42e-04 | 1441 | 206 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | chromosome segregation | BCL7B SPDL1 ARID1B HECW2 KIF2A NIPBL PSRC1 APC PUM2 INO80 TEX14 EML3 HASPIN DYNC1LI1 | 2.55e-04 | 465 | 206 | 14 | GO:0007059 |
| GeneOntologyBiologicalProcess | spindle checkpoint signaling | 2.60e-04 | 57 | 206 | 5 | GO:0031577 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome segregation | 2.60e-04 | 57 | 206 | 5 | GO:0051985 | |
| GeneOntologyBiologicalProcess | neuron development | TRIO UBE4B MAPT ADGRV1 CUL7 NPHP4 GFI1 CNTN6 NKX2-8 ARID1B HECW2 KCNQ2 HERC1 CX3CL1 CACNA1A DSCAM ITSN1 APC TRIOBP PUM2 PCARE GRIP1 SLC4A10 RIMS1 RERE MARK2 ULK2 TNXB CUX1 | 3.11e-04 | 1463 | 206 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | synaptic signaling | TRIO MAPT SYNPO STIM1 ARID1B SYNJ1 GPR158 KMT2A KCNQ2 BSN CX3CL1 CACNA1A CACNA1B SORBS2 GRIN2C SHISA7 GRIP1 SLC4A10 CHRD RIMS1 NRG3 IGSF21 | 3.19e-04 | 976 | 206 | 22 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 3.31e-04 | 60 | 206 | 5 | GO:0033047 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 3.45e-04 | 217 | 206 | 9 | GO:0000075 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | CUL7 SPDL1 KIF2A NIPBL PSRC1 APC INO80 TEX14 EML3 HASPIN DYNC1LI1 | 3.52e-04 | 316 | 206 | 11 | GO:0140014 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 4.47e-04 | 64 | 206 | 5 | GO:0045839 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 4.47e-04 | 64 | 206 | 5 | GO:0010965 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 5.00e-04 | 16 | 206 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | MAPT SYNPO CUL7 NPHP4 BMP2 TTBK1 SYNJ1 NABP2 CX3CL1 PSRC1 ADGRL3 CACNA1B DSCAM ITSN1 APC PUM2 IRX3 INO80 GRIP1 VPS13D EIF4G1 MEIOSIN LIMCH1 RIMS1 MARK2 TNXB CUX1 | 5.33e-04 | 1366 | 206 | 27 | GO:0051130 |
| GeneOntologyBiologicalProcess | chromosome organization | MAPT BCL7B POGZ SPDL1 ARID1B HECW2 NABP2 KIF2A NIPBL PSRC1 APC PUM2 INO80 TEX14 EML3 HASPIN DYNC1LI1 | 5.51e-04 | 686 | 206 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 5.53e-04 | 67 | 206 | 5 | GO:0051306 | |
| GeneOntologyBiologicalProcess | cerebellum maturation | 5.88e-04 | 4 | 206 | 2 | GO:0021590 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 6.20e-04 | 144 | 206 | 7 | GO:0051261 | |
| GeneOntologyBiologicalProcess | organelle fission | MAPT CUL7 SPDL1 KIF2A NIPBL PSRC1 ZNF541 APC INO80 TEX14 EML3 INF2 HASPIN DYNC1LI1 MEIOSIN | 6.47e-04 | 571 | 206 | 15 | GO:0048285 |
| GeneOntologyBiologicalProcess | chromatin organization | METTL3 BCL7B BAP1 EZHIP ZNF462 ARID1B KMT2A MLLT3 UHRF2 NIPBL SFMBT1 RPS6KA4 EP400 INO80 YEATS2 BAZ2A MDC1 HASPIN RERE ZNF445 | 6.80e-04 | 896 | 206 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MAPT SYNPO SVIL PKD1 CX3CL1 PSRC1 ARHGEF19 APC TRIOBP SHROOM2 EML3 TJP1 KANK4 LIMCH1 MARK2 | 7.46e-04 | 579 | 206 | 15 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 8.20e-04 | 73 | 206 | 5 | GO:0051784 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 8.51e-04 | 246 | 206 | 9 | GO:1902806 | |
| GeneOntologyCellularComponent | microtubule | MAPT NCKAP5 STIM1 SYNJ1 SVIL KIF2A MTUS2 PSRC1 AKNA APC INO80 SHROOM2 EML3 TTLL7 GRIP1 DYNC1LI1 CEP170B | 2.94e-05 | 533 | 210 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAPT EVPL NCKAP5 STIM1 SYNJ1 SVIL KIF2A MTUS2 PSRC1 WIPF1 AKNA APC INO80 SHROOM2 EML3 TTLL7 SMTN GRIP1 INF2 DYNC1LI1 MARK2 CEP170B | 1.10e-04 | 899 | 210 | 22 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | MAPT EVPL NCKAP5 SYNPO STIM1 SYNJ1 SVIL KIF2A MTUS2 PSRC1 SORBS2 WIPF1 AKNA APC INO80 SHROOM2 EML3 TTLL7 SMTN GRIP1 INF2 DYNC1LI1 LTBP1 MARK2 CEP170B | 3.43e-04 | 1179 | 210 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MAPT EVPL NCKAP5 SYNPO STIM1 SYNJ1 SVIL KIF2A MTUS2 PSRC1 SORBS2 WIPF1 AKNA APC INO80 SHROOM2 EML3 TTLL7 SMTN GRIP1 INF2 DYNC1LI1 LTBP1 MARK2 CEP170B | 3.79e-04 | 1187 | 210 | 25 | GO:0099081 |
| HumanPheno | Long philtrum | TRIO UBE4B CUL7 BAP1 BMP2 ARID1B RIN2 FGF3 KMT2A NIPBL TBX1 PCDHGC4 APC MADD SLC4A10 LTBP1 RERE SPEN | 7.74e-06 | 429 | 68 | 18 | HP:0000343 |
| HumanPheno | Abnormal morphology of the nasal alae | TRIO POGZ CUL7 BAP1 ZNF462 BMP2 ARID1B PIK3C2A HECW2 FGF3 KMT2A NIPBL TBX1 CACNA1B APC MADD GRIP1 SLC4A10 ANKRD17 LTBP1 RERE SPEN | 1.46e-05 | 639 | 68 | 22 | HP:0000429 |
| HumanPheno | Downslanted palpebral fissures | TRIO POGZ BAP1 ZNF462 BMP2 ARID1B SYNJ1 RIN2 FGF3 KMT2A HERC1 TBX1 CACNA1A CACNA1B DOK7 APC LTBP1 RERE SPEN | 1.57e-05 | 497 | 68 | 19 | HP:0000494 |
| HumanPheno | Abnormal nasal tip morphology | TRIO POGZ CUL7 ZNF462 ARID1B HECW2 KMT2A TBX1 APC MADD GRIP1 LTBP1 RERE SRRM2 SPEN CUX1 | 3.26e-05 | 386 | 68 | 16 | HP:0000436 |
| HumanPheno | Abnormality of the philtrum | TRIO UBE4B POGZ CUL7 BAP1 STIM1 ZNF462 BMP2 ARID1B RIN2 FGF3 KMT2A NIPBL TBX1 PCDHGC4 APC MADD SLC4A10 ANKRD17 LTBP1 RERE SRRM2 SPEN | 3.43e-05 | 726 | 68 | 23 | HP:0000288 |
| HumanPheno | Abnormal external nose morphology | TRIO UBE4B POGZ CUL7 BAP1 ZNF462 BMP2 ARID1B PIK3C2A HECW2 FGF3 KMT2A NIPBL TBX1 CACNA1B PCDHGC4 APC MADD GRIP1 SLC4A10 ANKRD17 LTBP1 RERE SRRM2 SPEN CUX1 | 5.91e-05 | 916 | 68 | 26 | HP:0010938 |
| HumanPheno | Abnormal upper lip morphology | TRIO UBE4B EVC POGZ CUL7 BAP1 STIM1 ZNF462 BMP2 ARID1B RIN2 FGF3 KMT2A NIPBL TBX1 CACNA1A PCDHGC4 APC MADD GRIP1 SLC4A10 ANKRD17 LTBP1 RERE SRRM2 SPEN CUX1 | 6.73e-05 | 980 | 68 | 27 | HP:0000177 |
| HumanPheno | Restricted or repetitive behaviors or interests | TRIO UBE4B MAPT POGZ ADGRV1 ARID1B HECW2 KMT2A NIPBL TBX1 CACNA1B MADD SLC4A10 RERE SPEN | 7.36e-05 | 368 | 68 | 15 | HP:0031432 |
| HumanPheno | Perseverative thought | TRIO UBE4B MAPT POGZ ADGRV1 ARID1B HECW2 KMT2A NIPBL TBX1 CACNA1B MADD SLC4A10 RERE SPEN | 9.70e-05 | 377 | 68 | 15 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TRIO UBE4B MAPT POGZ ADGRV1 ARID1B HECW2 KMT2A NIPBL TBX1 CACNA1B MADD SLC4A10 RERE SPEN | 1.27e-04 | 386 | 68 | 15 | HP:0025769 |
| MousePheno | abnormal CNS synaptic transmission | ZNF609 MAPT EMILIN3 SYNPO POGZ ADGRV1 PTPN4 ARID1B SYNJ1 GPR158 KCNQ2 DLAT BSN DNMBP TBX1 CACNA1A CACNA1B SORBS2 TRIB2 TTC28 ITSN1 ADNP2 TRIOBP GRIN2C SHISA7 MADD EIF4G1 CHRD NRG3 IGSF21 | 5.94e-06 | 985 | 177 | 30 | MP:0002206 |
| MousePheno | abnormal response to novelty | MAPT POGZ XKR4 FAM53C STIM1 ARID1B TTBK1 RIN2 KCNQ2 DLAT CX3CL1 TBX1 CACNA1B SORBS2 TRIB2 ITSN1 ADNP2 INO80 ZNRF2 SHISA7 ZFHX4 EIF4G1 SLC4A10 CHRD DYNC1LI1 NRG3 | 6.51e-06 | 787 | 177 | 26 | MP:0003107 |
| MousePheno | abnormal synaptic transmission | ZNF609 MAPT EMILIN3 SYNPO POGZ ADGRV1 KCNH6 PTPN4 ARID1B SYNJ1 GPR158 KCNQ2 DLAT BSN DNMBP TBX1 CACNA1A CACNA1B SORBS2 TRIB2 TTC28 ITSN1 ADNP2 TRIOBP GRIN2C SHISA7 MADD EIF4G1 CHRD NRG3 IGSF21 | 1.11e-05 | 1070 | 177 | 31 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | ZNF609 MAPT EMILIN3 SYNPO POGZ ADGRV1 KCNH6 PTPN4 ARID1B SYNJ1 GPR158 KCNQ2 DLAT BSN DNMBP TBX1 CACNA1A CACNA1B SORBS2 TRIB2 TTC28 ITSN1 ADNP2 TRIOBP GRIN2C SHISA7 MADD EIF4G1 CHRD NRG3 IGSF21 | 1.24e-05 | 1076 | 177 | 31 | MP:0021009 |
| MousePheno | abnormal response to new environment | MAPT XKR4 FAM53C STIM1 ARID1B TTBK1 RIN2 KCNQ2 DLAT CX3CL1 CACNA1B SORBS2 TRIB2 ITSN1 ADNP2 INO80 ZNRF2 SHISA7 ZFHX4 SLC4A10 CHRD DYNC1LI1 NRG3 | 1.90e-05 | 687 | 177 | 23 | MP:0001413 |
| MousePheno | abnormal exploration in a new environment | MAPT XKR4 FAM53C STIM1 ARID1B TTBK1 RIN2 KCNQ2 DLAT CX3CL1 CACNA1B SORBS2 TRIB2 ITSN1 ADNP2 INO80 ZNRF2 SHISA7 ZFHX4 CHRD DYNC1LI1 NRG3 | 2.32e-05 | 647 | 177 | 22 | MP:0013189 |
| MousePheno | decreased exploration in new environment | MAPT XKR4 FAM53C STIM1 ARID1B TTBK1 RIN2 KCNQ2 DLAT CX3CL1 SORBS2 TRIB2 ITSN1 ADNP2 INO80 ZNRF2 ZFHX4 CHRD DYNC1LI1 | 2.53e-05 | 510 | 177 | 19 | MP:0001417 |
| MousePheno | impaired conditioning behavior | MAPT POGZ ARID1B UHRF2 CACNA1B SORBS2 ITSN1 SHISA7 EIF4G1 NRG3 | 4.73e-05 | 165 | 177 | 10 | MP:0012317 |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 1.12e-04 | 116 | 177 | 8 | MP:0004753 | |
| MousePheno | postnatal growth retardation | MAPT GFI1 GGA3 ITPKB STIM1 ZNF462 GRHL1 ARID1B SYNJ1 PIK3C2A PKD1 FBXO41 KMT2A NIPBL TRIB2 DSCAM ITSN1 APC SHISA2 SMTN MDC1 SLC4A10 RERE MARK2 CUX1 | 1.22e-04 | 881 | 177 | 25 | MP:0001732 |
| MousePheno | abnormal learning/memory/conditioning | MAPT SYNPO POGZ XKR4 FAM53C STIM1 PTPN4 ARID1B TTBK1 RIN2 KCNQ2 DLAT UHRF2 CX3CL1 TBX1 NPAS2 CACNA1B SORBS2 TRIB2 DSCAM ITSN1 ADNP2 INO80 ZNRF2 SHISA7 ZFHX4 EIF4G1 SLC4A10 CHRD DYNC1LI1 NRG3 | 1.78e-04 | 1239 | 177 | 31 | MP:0002063 |
| MousePheno | abnormal postnatal growth | MAPT GFI1 GGA3 ITPKB STIM1 ZNF462 GRHL1 ARID1B SYNJ1 PIK3C2A PKD1 FBXO41 KMT2A NIPBL TRIB2 DSCAM ITSN1 APC SHISA2 SMTN MDC1 SLC4A10 RERE MARK2 CUX1 | 1.92e-04 | 907 | 177 | 25 | MP:0001731 |
| MousePheno | abnormal cognition | MAPT SYNPO POGZ XKR4 FAM53C STIM1 PTPN4 ARID1B TTBK1 RIN2 KCNQ2 DLAT UHRF2 CX3CL1 TBX1 NPAS2 CACNA1B SORBS2 TRIB2 DSCAM ITSN1 ADNP2 INO80 ZNRF2 SHISA7 ZFHX4 EIF4G1 SLC4A10 CHRD DYNC1LI1 NRG3 | 1.97e-04 | 1246 | 177 | 31 | MP:0014114 |
| MousePheno | abnormal arcus anterior morphology | 2.24e-04 | 10 | 177 | 3 | MP:0009879 | |
| Domain | DH_1 | 5.52e-06 | 63 | 204 | 7 | PS00741 | |
| Domain | RhoGEF | 9.23e-06 | 68 | 204 | 7 | SM00325 | |
| Domain | RhoGEF | 1.12e-05 | 70 | 204 | 7 | PF00621 | |
| Domain | DH_2 | 1.12e-05 | 70 | 204 | 7 | PS50010 | |
| Domain | - | 1.23e-05 | 71 | 204 | 7 | 1.20.900.10 | |
| Domain | DH-domain | 1.23e-05 | 71 | 204 | 7 | IPR000219 | |
| Domain | PHD | 1.77e-05 | 75 | 204 | 7 | PF00628 | |
| Domain | Znf_PHD-finger | 2.49e-05 | 79 | 204 | 7 | IPR019787 | |
| Domain | GPS | 3.18e-05 | 34 | 204 | 5 | SM00303 | |
| Domain | Znf_FYVE_PHD | 3.48e-05 | 147 | 204 | 9 | IPR011011 | |
| Domain | GPS | 3.68e-05 | 35 | 204 | 5 | PF01825 | |
| Domain | GPS | 4.24e-05 | 36 | 204 | 5 | PS50221 | |
| Domain | GPS | 4.86e-05 | 37 | 204 | 5 | IPR000203 | |
| Domain | PHD | 5.41e-05 | 89 | 204 | 7 | SM00249 | |
| Domain | Znf_PHD | 6.24e-05 | 91 | 204 | 7 | IPR001965 | |
| Domain | ZF_PHD_2 | 8.21e-05 | 95 | 204 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 8.77e-05 | 96 | 204 | 7 | PS01359 | |
| Domain | SANT | 2.10e-04 | 50 | 204 | 5 | SM00717 | |
| Domain | SANT/Myb | 2.54e-04 | 52 | 204 | 5 | IPR001005 | |
| Domain | ELM2_dom | 3.39e-04 | 13 | 204 | 3 | IPR000949 | |
| Domain | ELM2 | 3.39e-04 | 13 | 204 | 3 | PF01448 | |
| Domain | ELM2 | 3.39e-04 | 13 | 204 | 3 | PS51156 | |
| Domain | ELM2 | 3.39e-04 | 13 | 204 | 3 | SM01189 | |
| Domain | Neuregulin_C | 3.54e-04 | 3 | 204 | 2 | IPR002154 | |
| Domain | Neuregulin | 3.54e-04 | 3 | 204 | 2 | PF02158 | |
| Domain | SEA | 4.28e-04 | 14 | 204 | 3 | SM00200 | |
| Domain | - | 5.30e-04 | 15 | 204 | 3 | 3.30.70.960 | |
| Domain | Myb_DNA-binding | 5.55e-04 | 35 | 204 | 4 | PF00249 | |
| Domain | UBA | 6.19e-04 | 36 | 204 | 4 | PF00627 | |
| Domain | AT_hook | 6.47e-04 | 16 | 204 | 3 | PF02178 | |
| Domain | YEATS | 7.02e-04 | 4 | 204 | 2 | PS51037 | |
| Domain | YEATS | 7.02e-04 | 4 | 204 | 2 | IPR005033 | |
| Domain | REJ | 7.02e-04 | 4 | 204 | 2 | PS51111 | |
| Domain | REJ_dom | 7.02e-04 | 4 | 204 | 2 | IPR014010 | |
| Domain | YEATS | 7.02e-04 | 4 | 204 | 2 | PF03366 | |
| Domain | MYB_LIKE | 7.63e-04 | 38 | 204 | 4 | PS50090 | |
| Domain | GDS_CDC24_CS | 8.43e-04 | 39 | 204 | 4 | IPR001331 | |
| Domain | PDZ | 9.21e-04 | 141 | 204 | 7 | PF00595 | |
| Domain | PH | TRIO PLEKHG1 OSBPL11 ARHGEF19 ARHGAP23 PLEKHG7 DOK7 ITSN1 TRIOBP PLEKHG3 | 9.95e-04 | 278 | 204 | 10 | SM00233 |
| Domain | PH_DOMAIN | TRIO PLEKHG1 OSBPL11 ARHGEF19 ARHGAP23 PLEKHG7 DOK7 ITSN1 TRIOBP PLEKHG3 | 1.02e-03 | 279 | 204 | 10 | PS50003 |
| Domain | PH_domain | TRIO PLEKHG1 OSBPL11 ARHGEF19 ARHGAP23 PLEKHG7 DOK7 ITSN1 TRIOBP PLEKHG3 | 1.05e-03 | 280 | 204 | 10 | IPR001849 |
| Domain | Homeodomain-like | MIER3 POGZ NKX2-8 ZNF541 EP400 ADNP2 IRX3 ZFHX4 RERE CDC5L CUX1 | 1.10e-03 | 332 | 204 | 11 | IPR009057 |
| Domain | Gal_Lectin | 1.16e-03 | 5 | 204 | 2 | PF02140 | |
| Domain | Lectin_gal-bd_dom | 1.16e-03 | 5 | 204 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.16e-03 | 5 | 204 | 2 | PS50228 | |
| Domain | PDZ | 1.22e-03 | 148 | 204 | 7 | SM00228 | |
| Domain | UBA | 1.33e-03 | 44 | 204 | 4 | IPR015940 | |
| Domain | PDZ | 1.37e-03 | 151 | 204 | 7 | PS50106 | |
| Domain | PDZ | 1.43e-03 | 152 | 204 | 7 | IPR001478 | |
| Domain | SH3_9 | 1.64e-03 | 78 | 204 | 5 | PF14604 | |
| Domain | SEA | 1.70e-03 | 22 | 204 | 3 | PF01390 | |
| Domain | UBA | 1.71e-03 | 47 | 204 | 4 | PS50030 | |
| Domain | SPOC_C | 1.73e-03 | 6 | 204 | 2 | IPR012921 | |
| Domain | PKD/REJ-like | 1.73e-03 | 6 | 204 | 2 | IPR002859 | |
| Domain | REJ | 1.73e-03 | 6 | 204 | 2 | PF02010 | |
| Domain | SPOC | 1.73e-03 | 6 | 204 | 2 | PF07744 | |
| Domain | SEA | 1.94e-03 | 23 | 204 | 3 | PS50024 | |
| Domain | SEA_dom | 1.94e-03 | 23 | 204 | 3 | IPR000082 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 UBE4B MAPT ZC3H13 POGZ FAM53C BAP1 CACTIN ZC3H4 SVIL OSBPL11 KMT2A DNMBP NIPBL SORBS2 EP400 PHF12 ITSN1 PARG PHRF1 PUM2 PHC2 SMTN YEATS2 PRICKLE3 BAZ2A PHF3 MDC1 EIF4G1 DYNC1LI1 ANKRD17 LIMCH1 RIMS1 RERE MARK2 SRRM2 SPEN | 6.56e-22 | 774 | 218 | 37 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 TRIO MAPT FAM53C ITPKB STIM1 PLEKHG1 SYNJ1 PIK3C2A SVIL CGN KMT2A KIF2A DNMBP CRTC3 SORBS2 TTC28 DTL APC ZNRF2 PPP4R4 MADD C6orf132 KIAA1671 GRIP1 VPS13D TJP1 PHF3 PLEKHG3 EIF4G1 ANKRD17 CEP131 LIMCH1 MARK2 SRRM2 SH3RF3 USP6NL CEP170B | 2.73e-21 | 861 | 218 | 38 | 36931259 |
| Pubmed | MAPT SYNPO XKR4 SYNJ1 PIK3C2A FBXO41 KCNQ2 BSN ADGRL3 CACNA1A CACNA1B ITSN1 APC NRG2 MADD SLC4A10 RIMS1 MARK2 SRRM2 CEP170B | 9.09e-14 | 347 | 218 | 20 | 17114649 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 TRIO UBE4B SPEG NPHP4 BAP1 GGA3 PPP1R26 PRR12 PLEKHG1 SYNJ1 PKD1 KCNQ2 HERC1 DNMBP ARHGEF19 EP400 ATP13A1 PHF12 AOC2 AKNA INO80 EML3 MADD PHC2 C6orf132 LATS2 INF2 EIF4G1 CEP131 SPEN ULK2 CEP170B | 1.11e-13 | 1105 | 218 | 33 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 ZNF609 BCL7B POGZ ZNF462 PRR12 ARID1B KMT2A UHRF2 NIPBL EP400 PHF12 DTL INO80 KIAA1671 TRIM33 ZFHX4 MDC1 RERE SPEN | 1.13e-13 | 351 | 218 | 20 | 38297188 |
| Pubmed | UBE4B SPEG POGZ GGA3 PLEKHG1 ADGRL3 SORBS2 EP400 TTC28 PUM2 MADD YEATS2 BAZ2A PHF3 LIMCH1 RERE SRRM2 SPEN ULK2 RUBCN CEP170B | 1.83e-13 | 407 | 218 | 21 | 12693553 | |
| Pubmed | NCOA6 ZNF609 SYNPO POGZ ADGRV1 BAP1 GGA3 ARID1B ZC3H4 HECW2 FBXO41 BSN DNMBP EP400 PHF12 PHRF1 AKNA TRIOBP INO80 TRIM33 MDC1 ANKRD17 USP6NL | 4.38e-13 | 529 | 218 | 23 | 14621295 | |
| Pubmed | NCOA6 ZNF609 BCL7B BAP1 PRR12 GRHL1 ARID1B ZC3H4 KMT2A NIPBL EP400 PHF12 TRIM33 PHF3 MDC1 RERE CUX1 | 1.51e-12 | 268 | 218 | 17 | 33640491 | |
| Pubmed | ZNF609 POGZ BAP1 SPDL1 ZNF462 PRR12 SYNJ1 SFMBT1 TBC1D15 TTC28 PHF12 APC RBM20 KIAA1671 YEATS2 ZFHX4 ANKRD17 CEP131 RERE CUX1 | 2.81e-12 | 418 | 218 | 20 | 34709266 | |
| Pubmed | NCOA6 POGZ GGA3 SPDL1 ARID1B SYNJ1 CGN OSBPL11 KMT2A TBC1D15 EP400 TTC28 KIAA1671 YEATS2 BAZ2A TJP1 PHF3 MDC1 ZFR CDC5L SPEN CUX1 | 7.17e-12 | 549 | 218 | 22 | 38280479 | |
| Pubmed | TRIO SYNPO ZNF462 SYNJ1 GPR158 ZC3H4 SVIL FBXO41 KIF2A BSN NIPBL CACNA1A SORBS2 DSCAM ITSN1 APC TRIOBP SHISA7 TJP1 EIF4G1 ANKRD17 ZFR CEP131 LIMCH1 RIMS1 CDC5L CEP170B CUX1 | 1.79e-11 | 963 | 218 | 28 | 28671696 | |
| Pubmed | CUL7 PLEKHG1 ARID1B PIK3C2A CGN KIF2A CRTC3 SORBS2 TTC28 APC KIAA1671 GRIP1 ANKRD44 LATS2 TJP1 CEP131 MARK2 SH3RF3 CEP170B | 7.35e-11 | 446 | 218 | 19 | 24255178 | |
| Pubmed | NCOA6 ZNF609 BCL7B POGZ CUL7 BAP1 ZNF462 PRR12 ARID1B SVIL SLX4IP KMT2A DLAT HERC1 NIPBL EP400 PHF12 PUM2 INO80 RBM20 KIAA1671 TRIM33 YEATS2 ZFHX4 MDC1 EIF4G1 ANKRD17 ZFR CEP131 RERE SRRM2 SPEN CUX1 | 1.07e-10 | 1429 | 218 | 33 | 35140242 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 TRIO UBE4B MAPT EVC SYNPO ADGRV1 ITPKB ZNF462 PTPN4 GPR158 RIN2 SLX4IP RECK NPAS2 TRIOBP SHROOM2 PPP4R4 KIAA1671 ANKRD44 YEATS2 LATS2 INF2 TJP1 PLEKHG3 ANKRD17 LIMCH1 RIMS1 RERE NRG3 SH3RF3 CEP170B CUX1 | 3.05e-10 | 1489 | 218 | 33 | 28611215 |
| Pubmed | TRIO UBE4B NCKAP5 SYNPO POGZ FAM53C SYNJ1 NABP2 PKD1 KCNQ2 DLAT MLLT3 NIPBL MTUS2 RECK SORBS2 DSCAM TTC28 ATP13A1 ITSN1 ADNP2 APC TRIOBP ANKRD6 SHROOM2 MADD TRIM33 TJP1 EIF4G1 CUX1 | 6.40e-10 | 1285 | 218 | 30 | 35914814 | |
| Pubmed | METTL3 PRR12 PIK3C2A KMT2A KIF2A DNMBP NIPBL EP400 ATP13A1 PHF12 PHRF1 APC TRIOBP PUM2 DHX57 INO80 PHC2 C6orf132 KIAA1671 TRIM33 BAZ2A PHF3 PLEKHG3 MDC1 EIF4G1 ANKRD17 CEP131 LIMCH1 MARK2 SPEN USP6NL CEP170B | 1.42e-09 | 1497 | 218 | 32 | 31527615 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TRIO PRR12 SYNJ1 GPR158 MTUS2 CACNA1A CACNA1B ARHGAP23 APC DHX57 INO80 SHISA7 MADD KANK4 DYNC1LI1 ZFR LIMCH1 CDC5L | 1.52e-09 | 475 | 218 | 18 | 31040226 |
| Pubmed | TRIO MAPT SYNPO ITPKB SYNJ1 HECW2 SVIL FBXO41 KMT2A KCNQ2 DLAT KIF2A BSN MTUS2 CACNA1A SORBS2 ARHGAP23 ITSN1 APC DHX57 SHROOM2 MADD INF2 TJP1 EIF4G1 SLC4A10 LIMCH1 RIMS1 MARK2 CDC5L CEP170B | 1.92e-09 | 1431 | 218 | 31 | 37142655 | |
| Pubmed | ZNF609 MAPT BCL7B EMILIN3 POGZ CUL7 FAM53C CACTIN ARID1B ZC3H4 DLAT EP400 TTC28 ARHGAP23 PHF12 PHRF1 ADNP2 INO80 KIAA1671 TRIM33 YEATS2 ZFHX4 BAZ2A ANKRD17 RERE SRRM2 CEP170B | 2.34e-09 | 1116 | 218 | 27 | 31753913 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MAPT SPEG SYNPO FBXO41 BSN CACNA1B ITSN1 SLC4A10 DYNC1LI1 RIMS1 MARK2 SRRM2 CEP170B | 2.94e-09 | 231 | 218 | 13 | 16452087 |
| Pubmed | TRIO MAPT SYNPO STIM1 SYNJ1 GPR158 FBXO41 KCNQ2 DLAT KIF2A BSN ADGRL3 CACNA1A CACNA1B SORBS2 ATP13A1 APC TRIOBP SHROOM2 SHISA7 MADD TJP1 SLC4A10 DYNC1LI1 CEP131 RIMS1 CEP170B | 3.61e-09 | 1139 | 218 | 27 | 36417873 | |
| Pubmed | NCOA6 ADGRV1 BAP1 ZNF462 SYNJ1 GPR158 ZC3H4 TTC28 TRIOBP PUM2 PHF3 CDC5L | 2.20e-08 | 225 | 218 | 12 | 12168954 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | NPHP4 PRR12 PIK3C2A SVIL SMTN TRIM33 YEATS2 TJP1 CEP131 SPEN CEP170B | 2.67e-08 | 184 | 218 | 11 | 32908313 |
| Pubmed | ZNF609 TRIO SPDL1 ARID1B EP400 TTC28 ATP13A1 ITSN1 DTL APC PUM2 MADD YEATS2 SPINT2 TJP1 PHF3 MDC1 DYNC1LI1 CEP131 CDC5L | 4.62e-08 | 733 | 218 | 20 | 34672954 | |
| Pubmed | 5.52e-08 | 83 | 218 | 8 | 28794006 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 ZNF609 GGA3 TMEM132C BSN ADGRL3 CRTC3 EP400 ITSN1 TEX14 C6orf132 KIAA1671 MDC1 ZFR SPEN | 1.08e-07 | 430 | 218 | 15 | 35044719 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 ZNF609 ZC3H13 POGZ ARID1B ZC3H4 SLX4IP KMT2A NIPBL EP400 TRIM33 YEATS2 BAZ2A TJP1 PHF3 MDC1 EIF4G1 ZFR CDC5L SRRM2 SPEN CUX1 | 1.79e-07 | 954 | 218 | 22 | 36373674 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.88e-07 | 134 | 218 | 9 | 25452129 | |
| Pubmed | ZC3H13 POGZ CUL7 CGN KMT2A DLAT NIPBL PHRF1 DHX57 BAZ2A TJP1 PHF3 MDC1 EIF4G1 ANKRD17 ZFR SRRM2 SPEN | 1.92e-07 | 653 | 218 | 18 | 22586326 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | METTL3 CUL7 SYNJ1 BSN DNMBP EP400 TTC28 ITSN1 DTL APC RBM20 KIAA1671 TRIM33 YEATS2 CEP131 SPEN CEP170B | 2.19e-07 | 588 | 218 | 17 | 38580884 |
| Pubmed | NCOA6 ZNF609 TRIO SPDL1 ARID1B ZC3H4 EP400 ITSN1 SMTN YEATS2 PHF3 DYNC1LI1 CEP131 SRRM2 CUX1 | 3.54e-07 | 472 | 218 | 15 | 38943005 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 4.89e-07 | 150 | 218 | 9 | 28242625 | |
| Pubmed | EVPL SVIL CGN NIPBL SORBS2 APC TRIOBP TJP1 EIF4G1 DYNC1LI1 ZFR CDC5L SRRM2 | 5.26e-07 | 360 | 218 | 13 | 33111431 | |
| Pubmed | CUL7 NPHP4 PPP1R26 ZNF462 PRR12 TTBK1 CGN ADGRF5 ARHGAP23 ATP13A1 ANKRD6 PPP4R4 VPS13D PLEKHG3 CDC5L | 6.12e-07 | 493 | 218 | 15 | 15368895 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | NCOA6 POGZ CUL7 FAM53C BAP1 SPDL1 ZNF462 KMT2A SFMBT1 ADNP2 INO80 PHC2 YEATS2 EIF4G1 RERE | 6.44e-07 | 495 | 218 | 15 | 27705803 |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | EMILIN3 SYNPO ADGRV1 ARID1B KIF2A TBC1D15 WIPF1 TTC28 PUM2 PPP4R4 ZFHX4 BAZ2A RERE SRRM2 | 6.78e-07 | 431 | 218 | 14 | 33660365 |
| Pubmed | ZC3H13 CNTN6 CACTIN ZC3H4 CGN PKD1 COL14A1 NIPBL PSRC1 CTAGE9 CRTC3 SORBS2 TRIB2 ARHGAP23 AOC2 EML3 MOSPD1 TRIM33 TJP1 PLEKHG3 CTAGE8 KANK4 RUBCN CEP170B | 7.83e-07 | 1215 | 218 | 24 | 15146197 | |
| Pubmed | METTL3 ZC3H13 ZC3H4 OSBPL11 NIPBL PSRC1 TBC1D15 DTL APC PHF3 EIF4G1 CEP131 MARK2 SRRM2 SPEN | 7.86e-07 | 503 | 218 | 15 | 16964243 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 MAPT POGZ STIM1 PIK3C2A ZC3H4 DNMBP APC TRIOBP PUM2 DHX57 INO80 TJP1 PHF3 EIF4G1 ANKRD17 ZFR SPEN | 8.55e-07 | 724 | 218 | 18 | 36232890 |
| Pubmed | ZNF609 PRR12 ZC3H4 OSBPL11 KMT2A KIF2A TTC28 ARHGAP23 PARG APC DHX57 RBM20 MADD ANKRD17 MARK2 PCDHGC3 RUBCN | 8.76e-07 | 650 | 218 | 17 | 38777146 | |
| Pubmed | GGA3 SVIL DNMBP TTC28 ITSN1 APC C6orf132 KIAA1671 LATS2 TJP1 USP6NL | 9.69e-07 | 263 | 218 | 11 | 34702444 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ZNF609 BCL7B POGZ BAP1 ARID1B ZC3H4 SVIL NIPBL DTL APC TRIOBP EML3 SMTN INF2 PRICKLE3 TJP1 EIF4G1 DYNC1LI1 ZFR CEP131 MARK2 CDC5L CEP170B | 1.18e-06 | 1155 | 218 | 23 | 20360068 |
| Pubmed | ZNF609 EZHIP PRR12 ARID1B ZC3H4 SLX4IP KIF2A EP400 PHF12 SMTN TRIM33 PHF3 MDC1 ZFR | 1.22e-06 | 453 | 218 | 14 | 29656893 | |
| Pubmed | NCKAP5 CUL7 PTPN4 PKD1 WIPF1 SHROOM2 PRICKLE3 BAZ2A CHRD RIMS1 SPEN FYB1 | 1.31e-06 | 329 | 218 | 12 | 17474147 | |
| Pubmed | TCERG1L SYNPO KMT2A DLAT CTAGE4 BSN NIPBL TBX1 ZNF541 PCDHGC4 ITSN1 DTL DHX57 TEX14 C2orf78 PPP4R4 LATS2 TJP1 CTAGE8 EIF4G1 ZFR LIMCH1 RIMS1 SPEN PCDHGC3 CUX1 | 1.45e-06 | 1442 | 218 | 26 | 35575683 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZC3H13 POGZ ZNF462 ARID1B ZC3H4 KIF2A NIPBL NPAS2 SORBS2 EP400 APC TRIOBP DHX57 INO80 PHC2 TJP1 EIF4G1 DYNC1LI1 CDC5L SRRM2 SPEN TNXB | 1.45e-06 | 1082 | 218 | 22 | 38697112 |
| Pubmed | ZNF609 ARID1B EP400 MUC16 INO80 PHC2 TRIM33 YEATS2 MDC1 HASPIN DYNC1LI1 CDC5L SPEN | 1.52e-06 | 396 | 218 | 13 | 26687479 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZNF609 POGZ PRR12 ARID1B SYNJ1 EP400 ADNP2 APC RBM20 TRIM33 YEATS2 ZFHX4 CUX1 | 1.61e-06 | 398 | 218 | 13 | 35016035 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SYNPO POGZ BAP1 ZNF462 CACTIN KMT2A UHRF2 NIPBL PHF12 ADNP2 INO80 BAZ2A PHF3 MDC1 SPEN CUX1 | 1.71e-06 | 608 | 218 | 16 | 36089195 |
| Pubmed | 1.77e-06 | 130 | 218 | 8 | 12421765 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CUL7 ZC3H4 SVIL CGN KIF2A NIPBL TBC1D15 EP400 ZNRF2 KIAA1671 SPINT2 TJP1 PLEKHG3 MDC1 EIF4G1 ZFR CEP131 MARK2 CDC5L SRRM2 SPEN | 2.23e-06 | 1024 | 218 | 21 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 ZNF609 ZC3H13 POGZ BAP1 PRR12 CACTIN KMT2A NIPBL SFMBT1 EP400 PHF12 PHRF1 INO80 PHC2 YEATS2 BAZ2A PHF3 MDC1 ZFR CDC5L SRRM2 SPEN CUX1 | 2.34e-06 | 1294 | 218 | 24 | 30804502 |
| Pubmed | EVPL NCKAP5 SYNPO POGZ FAM53C KIAA1549L CRTC3 WIPF1 ITSN1 ADNP2 APC MADD ANKRD17 CUX1 | 2.76e-06 | 486 | 218 | 14 | 20936779 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | ZC3H13 SYNPO NPHP4 PRR12 ZC3H4 SVIL SORBS2 PHF12 APC TRIOBP KIAA1671 SRRM2 | 3.41e-06 | 361 | 218 | 12 | 30344098 |
| Pubmed | 4.11e-06 | 103 | 218 | 7 | 32744500 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 5.63e-06 | 108 | 218 | 7 | 19531213 | |
| Pubmed | NCOA6 ZNF609 BCL7B POGZ GFI1 PRR12 ARID1B KMT2A KIF2A UHRF2 NIPBL WIPF1 EP400 PHF12 TRIM33 YEATS2 DYNC1LI1 ZFR SRRM2 SPEN CUX1 | 6.99e-06 | 1103 | 218 | 21 | 34189442 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA6 ZNF609 PRR12 ARID1B PIK3C2A CRTC3 ATP13A1 PUM2 RBM20 TRIM33 YEATS2 ANKRD17 ZFR | 7.20e-06 | 457 | 218 | 13 | 32344865 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.27e-06 | 208 | 218 | 9 | 33230847 | |
| Pubmed | Synaptic, transcriptional and chromatin genes disrupted in autism. | 8.35e-06 | 7 | 218 | 3 | 25363760 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 8.35e-06 | 7 | 218 | 3 | 35176221 | |
| Pubmed | 1.07e-05 | 119 | 218 | 7 | 23508102 | ||
| Pubmed | ZNF609 TRIO CUL7 STIM1 CACTIN PTPN4 ARID1B SVIL CGN HERC1 TRIOBP RBM20 PPP4R4 MADD KIAA1671 TJP1 CEP131 LTBP1 CDC5L SRRM2 | 1.14e-05 | 1049 | 218 | 20 | 27880917 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 UBE4B POGZ ARID1B ZC3H4 KMT2A EP400 BAZ2A MDC1 SRRM2 SPEN | 1.16e-05 | 341 | 218 | 11 | 32971831 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | TRIO UBE4B SYNPO SYNJ1 SORBS2 SHISA7 PHF3 DYNC1LI1 RIMS1 CEP170B | 1.25e-05 | 281 | 218 | 10 | 28706196 |
| Pubmed | ZNF609 CUL7 ZNF462 OSBPL11 EP400 PHC2 TRIM33 ZFHX4 SPEN CUX1 | 1.29e-05 | 282 | 218 | 10 | 23667531 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EVPL GGA3 STIM1 SYNJ1 SVIL CGN ARHGAP23 C6orf132 KIAA1671 TJP1 EIF4G1 LIMCH1 MARK2 USP6NL | 1.51e-05 | 565 | 218 | 14 | 25468996 |
| Pubmed | 1.80e-05 | 233 | 218 | 9 | 37704626 | ||
| Pubmed | ZC3H13 EZHIP ARID1B SYNJ1 EXOC3L4 OSBPL11 KIF2A HERC1 ITSN1 DTL APC INO80 ANKRD6 SHROOM2 MADD SMTN INF2 ANKRD17 ULK2 ZNF445 | 1.83e-05 | 1084 | 218 | 20 | 11544199 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MIER3 NKX2-8 GRHL1 KMT2A MLLT3 TBX1 ZNF541 NPAS2 ADNP2 AKNA IRX3 BCL6B YEATS2 FOXD3 ZFHX4 SKOR1 RERE CDC5L | 1.91e-05 | 908 | 218 | 18 | 19274049 |
| Pubmed | 2.35e-05 | 27 | 218 | 4 | 36915679 | ||
| Pubmed | 2.72e-05 | 56 | 218 | 5 | 30022168 | ||
| Pubmed | IRX3/5 regulate mitotic chromatid segregation and limb bud shape. | 2.82e-05 | 10 | 218 | 3 | 32907847 | |
| Pubmed | TRIO SYNPO PPP1R26 STIM1 SYNJ1 EXOC3L4 SVIL TBC1D15 ADNP2 APC MADD TRIM33 INF2 PHF3 CEP131 | 3.36e-05 | 689 | 218 | 15 | 36543142 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | METTL3 POGZ KMT2A KIF2A NIPBL DHX57 INO80 PHC2 MDC1 HASPIN DYNC1LI1 LTBP1 SRRM2 | 3.60e-05 | 533 | 218 | 13 | 30554943 |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 20395514 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 3.91e-05 | 2 | 218 | 2 | 23426690 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 19247433 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 36181326 | ||
| Pubmed | Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias. | 3.91e-05 | 2 | 218 | 2 | 32768438 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 28331138 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 38576284 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 21959947 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 23376566 | ||
| Pubmed | A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease. | 3.91e-05 | 2 | 218 | 2 | 33852874 | |
| Pubmed | Nipbl Interacts with Zfp609 and the Integrator Complex to Regulate Cortical Neuron Migration. | 3.91e-05 | 2 | 218 | 2 | 28041881 | |
| Pubmed | The potential role of ubiquitin c-terminal hydrolases in oncogenesis. | 3.91e-05 | 2 | 218 | 2 | 20302916 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 38155373 | ||
| Pubmed | Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease. | 3.91e-05 | 2 | 218 | 2 | 23001711 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 34645714 | ||
| Pubmed | BAP1 promotes stalled fork restart and cell survival via INO80 in response to replication stress. | 3.91e-05 | 2 | 218 | 2 | 31657441 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 27344946 | ||
| Pubmed | Epithelial differentiation and intercellular junction formation in the mouse early embryo. | 3.91e-05 | 2 | 218 | 2 | 1299356 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 20808796 | ||
| Pubmed | Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer. | 3.91e-05 | 2 | 218 | 2 | 30606770 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 19591803 | ||
| Pubmed | MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells. | 3.91e-05 | 2 | 218 | 2 | 39002676 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 23178754 | ||
| Pubmed | GFI1 as a novel prognostic and therapeutic factor for AML/MDS. | 3.91e-05 | 2 | 218 | 2 | 26847026 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24849348 | ||
| Interaction | YWHAH interactions | NCOA6 TRIO MAPT SPEG ZC3H13 FAM53C BAP1 STIM1 PLEKHG1 PTPN4 SYNJ1 PIK3C2A SVIL CGN KMT2A KIF2A HERC1 DNMBP CRTC3 SORBS2 RPS6KA4 TTC28 DTL APC ZNRF2 EML3 PPP4R4 MADD C6orf132 TTLL7 KIAA1671 GRIP1 VPS13D LATS2 PRICKLE3 TJP1 PHF3 PLEKHG3 EIF4G1 ANKRD17 CEP131 LIMCH1 RIMS1 MARK2 SRRM2 SH3RF3 RUBCN USP6NL CEP170B | 1.25e-18 | 1102 | 207 | 49 | int:YWHAH |
| Interaction | YWHAG interactions | NCOA6 MAPT SPEG ZC3H13 SYNPO CUL7 FAM53C BAP1 ITPKB STIM1 PLEKHG1 PTPN4 TTBK1 SYNJ1 PIK3C2A SVIL CGN KMT2A KIF2A DNMBP CRTC3 SORBS2 RPS6KA4 TTC28 ARHGAP23 DTL APC SHROOM2 ZNRF2 EML3 PPP4R4 C6orf132 TTLL7 KIAA1671 GRIP1 VPS13D LATS2 PRICKLE3 TJP1 PHF3 PLEKHG3 EIF4G1 ANKRD17 CEP131 MARK2 CDC5L SRRM2 SH3RF3 RUBCN USP6NL CEP170B | 7.57e-18 | 1248 | 207 | 51 | int:YWHAG |
| Interaction | YWHAB interactions | MAPT SPEG CUL7 FAM53C BAP1 ITPKB STIM1 PTPN4 PIK3C2A SVIL CGN KMT2A KIF2A DNMBP CRTC3 SORBS2 RPS6KA4 TTC28 ARHGAP23 DTL APC EML3 PPP4R4 C6orf132 KIAA1671 GRIP1 TRIM33 VPS13D PRICKLE3 TJP1 PHF3 PLEKHG3 EIF4G1 DYNC1LI1 ANKRD17 CEP131 MARK2 SRRM2 SH3RF3 USP6NL CEP170B | 3.34e-14 | 1014 | 207 | 41 | int:YWHAB |
| Interaction | SFN interactions | NCOA6 MAPT FAM53C BAP1 PIK3C2A SVIL CGN KMT2A KIF2A DNMBP CRTC3 SORBS2 DTL APC TEX14 PPP4R4 C6orf132 KIAA1671 GRIP1 TJP1 PHF3 PLEKHG3 EIF4G1 ANKRD17 CEP131 MARK2 SRRM2 USP6NL CEP170B | 1.28e-10 | 692 | 207 | 29 | int:SFN |
| Interaction | YWHAZ interactions | MAPT SPEG SYNPO CUL7 FAM53C BAP1 STIM1 PTPN4 PIK3C2A SVIL CGN KMT2A DLAT KIF2A DNMBP CRTC3 SORBS2 TTC28 DTL APC EML3 PPP4R4 MADD C6orf132 KIAA1671 GRIP1 VPS13D LATS2 PRICKLE3 TJP1 PHF3 PLEKHG3 MDC1 DYNC1LI1 ANKRD17 CEP131 MARK2 CDC5L RUBCN USP6NL CEP170B | 1.46e-10 | 1319 | 207 | 41 | int:YWHAZ |
| Interaction | NUP43 interactions | NCOA6 ZNF609 ZC3H13 POGZ CUL7 GFER STIM1 ZNF462 CACTIN ARID1B KMT2A KIF2A NIPBL EP400 DSCAM PHF12 PHRF1 APC INO80 SMTN YEATS2 BAZ2A MDC1 EIF4G1 RERE SRRM2 SPEN | 3.04e-10 | 625 | 207 | 27 | int:NUP43 |
| Interaction | YWHAQ interactions | NCOA6 MAPT SPEG ZC3H13 CUL7 FAM53C BAP1 PTPN4 PIK3C2A SVIL CGN KMT2A DNMBP CRTC3 SORBS2 RPS6KA4 TTC28 ARHGAP23 DTL APC ZNRF2 EML3 PPP4R4 C6orf132 KIAA1671 GRIP1 VPS13D TJP1 PLEKHG3 EIF4G1 ANKRD17 CEP131 MARK2 CDC5L USP6NL CEP170B | 9.16e-10 | 1118 | 207 | 36 | int:YWHAQ |
| Interaction | EGR2 interactions | NCOA6 ZNF609 POGZ ZNF462 PRR12 ARID1B KMT2A NIPBL EP400 PHF12 INO80 TRIM33 ZFHX4 RERE | 2.76e-09 | 171 | 207 | 14 | int:EGR2 |
| Interaction | AFDN interactions | MAPT CUL7 FAM53C BAP1 CGN KMT2A DNMBP MTUS2 SORBS2 DSCAM APC KIAA1671 LATS2 PRICKLE3 TJP1 CEP131 MARK2 USP6NL | 1.12e-08 | 333 | 207 | 18 | int:AFDN |
| Interaction | MAPRE3 interactions | TRIO MAPT NCKAP5 STIM1 TTBK1 KIF2A DNMBP PSRC1 TTC28 APC C6orf132 KIAA1671 CEP131 MARK2 CEP170B | 1.66e-08 | 230 | 207 | 15 | int:MAPRE3 |
| Interaction | YWHAE interactions | MAPT CUL7 FAM53C BAP1 STIM1 PTPN4 PIK3C2A SVIL CGN KMT2A DNMBP CRTC3 ARHGEF19 SORBS2 TTC28 DTL APC SHROOM2 PPP4R4 C6orf132 TTLL7 KIAA1671 GRIP1 PRICKLE3 PLEKHG3 DYNC1LI1 ANKRD17 CEP131 LTBP1 MARK2 CDC5L SRRM2 SH3RF3 RUBCN USP6NL CEP170B | 1.94e-08 | 1256 | 207 | 36 | int:YWHAE |
| Interaction | FEV interactions | NCOA6 ZNF609 BCL7B POGZ BAP1 ZNF462 PRR12 ARID1B KMT2A NIPBL EP400 PHF12 ZFHX4 CUX1 | 2.50e-08 | 203 | 207 | 14 | int:FEV |
| Interaction | TOP3B interactions | NCOA6 TRIO UBE4B SPEG NPHP4 BAP1 GGA3 PPP1R26 PRR12 PLEKHG1 SYNJ1 SVIL PKD1 KCNQ2 DLAT HERC1 DNMBP ARHGEF19 EP400 ATP13A1 PHF12 AOC2 AKNA DHX57 INO80 EML3 MADD PHC2 C6orf132 LATS2 INF2 MDC1 EIF4G1 ANKRD17 ZFR CEP131 SPEN ULK2 CEP170B | 3.65e-08 | 1470 | 207 | 39 | int:TOP3B |
| Interaction | WWTR1 interactions | NCOA6 POGZ GGA3 SPDL1 ARID1B SYNJ1 CGN OSBPL11 KMT2A TBC1D15 EP400 TTC28 KIAA1671 YEATS2 LATS2 TJP1 PHF3 CDC5L CUX1 | 8.05e-08 | 422 | 207 | 19 | int:WWTR1 |
| Interaction | HNF4A interactions | NCOA6 ZNF609 POGZ BAP1 ZNF462 PRR12 ARID1B SLX4IP NIPBL EP400 PHF12 TRIM33 YEATS2 SPEN CUX1 | 1.74e-07 | 275 | 207 | 15 | int:HNF4A |
| Interaction | TERF2IP interactions | NCOA6 METTL3 ZNF609 BCL7B POGZ BAP1 CACTIN ZC3H4 SLX4IP KMT2A NIPBL EP400 TRIM33 YEATS2 BAZ2A TJP1 PHF3 MDC1 SRRM2 SPEN CUX1 | 2.76e-07 | 552 | 207 | 21 | int:TERF2IP |
| Interaction | TBXT interactions | 3.33e-07 | 116 | 207 | 10 | int:TBXT | |
| Interaction | HDAC1 interactions | METTL3 ZNF609 MIER3 GFI1 BAP1 SPDL1 SYNJ1 KMT2A KIF2A UHRF2 SFMBT1 TBC1D15 EP400 TTC28 PLEKHG7 PHF12 APC RBM20 KIAA1671 GRIP1 BCL6B YEATS2 LATS2 ZFHX4 BAZ2A SKOR1 ANKRD17 CEP131 RERE SPEN CUX1 | 3.65e-07 | 1108 | 207 | 31 | int:HDAC1 |
| Interaction | CBX3 interactions | MAPT ZC3H13 POGZ CUL7 BAP1 ZNF462 CACTIN ZC3H4 HECW2 KMT2A UHRF2 NIPBL EP400 ADNP2 TRIM33 YEATS2 BAZ2A PHF3 MDC1 SRRM2 SPEN CUX1 | 9.17e-07 | 646 | 207 | 22 | int:CBX3 |
| Interaction | FLNA interactions | TRIO MAPT SYNPO CUL7 NPHP4 BAP1 GGA3 SPDL1 PIK3C2A SVIL NIPBL SORBS2 DTL APC TRIM33 INF2 TJP1 PLEKHG3 MDC1 DYNC1LI1 RIMS1 SRRM2 | 9.65e-07 | 648 | 207 | 22 | int:FLNA |
| Interaction | KDM1A interactions | ZNF609 MAPT POGZ GFER GFI1 BAP1 SPDL1 ZNF462 PRR12 SYNJ1 SFMBT1 TBC1D15 EP400 TTC28 PHF12 APC RBM20 PHC2 KIAA1671 YEATS2 ZFHX4 PLEKHG3 ANKRD17 CEP131 RERE CDC5L CUX1 | 1.40e-06 | 941 | 207 | 27 | int:KDM1A |
| Interaction | MAPRE1 interactions | TRIO MAPT SYNPO BAP1 SPDL1 STIM1 TTBK1 SVIL KIF2A DNMBP MTUS2 PSRC1 SORBS2 APC EIF4G1 DYNC1LI1 CEP131 SRRM2 CEP170B | 1.61e-06 | 514 | 207 | 19 | int:MAPRE1 |
| Interaction | CAPZA2 interactions | UBE4B MAPT SYNPO CUL7 BAP1 PIK3C2A SVIL CGN SORBS2 PLEKHG7 TRIOBP KIAA1671 INF2 PLEKHG3 DYNC1LI1 LIMCH1 MARK2 | 2.37e-06 | 430 | 207 | 17 | int:CAPZA2 |
| Interaction | CRX interactions | ZNF609 BCL7B POGZ ZNF462 PRR12 ARID1B NIPBL NPAS2 EP400 TRIM33 ZFHX4 RERE SPEN | 2.39e-06 | 254 | 207 | 13 | int:CRX |
| Interaction | ACTN1 interactions | MAPT PCP2 SYNPO CUL7 NPHP4 BAP1 SVIL PKD1 KIF2A CACNA1A SORBS2 DSCAM APC TRIM33 TJP1 | 2.62e-06 | 341 | 207 | 15 | int:ACTN1 |
| Interaction | HDAC4 interactions | TRIO CUL7 FAM53C PRR12 SYNJ1 GPR158 CGN MTUS2 CACNA1A CACNA1B ARHGAP23 APC DHX57 INO80 SHISA7 MADD KANK4 DYNC1LI1 ZFR LIMCH1 MARK2 CDC5L SH3RF3 | 2.64e-06 | 744 | 207 | 23 | int:HDAC4 |
| Interaction | SP7 interactions | NCOA6 ZNF609 BCL7B POGZ PRR12 ARID1B NIPBL EP400 RBM20 TRIM33 ZFHX4 ZFR RERE CUX1 | 3.35e-06 | 304 | 207 | 14 | int:SP7 |
| Interaction | AR interactions | NCOA6 ZNF609 BCL7B BAP1 ZNF462 PRR12 GRHL1 ARID1B ZC3H4 SVIL CGN KMT2A NIPBL EP400 PHF12 GRIP1 TRIM33 LATS2 TJP1 PHF3 MDC1 ZFR CEP131 LIMCH1 RERE CDC5L CUX1 | 3.76e-06 | 992 | 207 | 27 | int:AR |
| Interaction | NFIX interactions | ZNF609 POGZ BAP1 PRR12 ARID1B KMT2A NIPBL EP400 PHF12 ZFHX4 SPEN CUX1 | 4.23e-06 | 227 | 207 | 12 | int:NFIX |
| Interaction | PFN1 interactions | TRIO CUL7 BAP1 GGA3 SYNJ1 PIK3C2A KIF2A DNMBP ZNF541 ITSN1 APC C6orf132 KIAA1671 INF2 TJP1 DYNC1LI1 CEP131 LIMCH1 | 5.64e-06 | 509 | 207 | 18 | int:PFN1 |
| Interaction | PAX6 interactions | NCOA6 ZNF609 BCL7B POGZ BAP1 ZNF462 PRR12 ARID1B SYNJ1 NIPBL EP400 DSCAM PHF12 ZFHX4 CUX1 | 6.17e-06 | 366 | 207 | 15 | int:PAX6 |
| Interaction | SOX9 interactions | 7.15e-06 | 97 | 207 | 8 | int:SOX9 | |
| Interaction | SNRNP40 interactions | ZNF609 ZC3H13 POGZ CUL7 ZNF462 CACTIN ARID1B ZC3H4 KMT2A EP400 PHF12 PHRF1 ADNP2 RBM20 YEATS2 BAZ2A MDC1 CDC5L SRRM2 SPEN | 9.84e-06 | 637 | 207 | 20 | int:SNRNP40 |
| Interaction | HDAC2 interactions | METTL3 ZNF609 TRIO MIER3 CUL7 GFI1 BAP1 STIM1 KMT2A COL14A1 SFMBT1 CRTC3 SORBS2 EP400 PHF12 DHX57 PHC2 LATS2 INF2 ANKRD17 LTBP1 RERE SRRM2 SPEN | 9.90e-06 | 865 | 207 | 24 | int:HDAC2 |
| Interaction | ASF1A interactions | NCOA6 ZC3H13 POGZ ARID1B KMT2A EP400 TRIM33 YEATS2 PHF3 MDC1 SPEN CUX1 | 1.08e-05 | 249 | 207 | 12 | int:ASF1A |
| Interaction | RCOR1 interactions | GFI1 BAP1 SPDL1 SYNJ1 UHRF2 SFMBT1 TBC1D15 TTC28 PHF12 APC RBM20 YEATS2 ZFHX4 ANKRD17 CEP131 SPEN CUX1 | 1.47e-05 | 494 | 207 | 17 | int:RCOR1 |
| Interaction | GAGE5 interactions | 1.50e-05 | 52 | 207 | 6 | int:GAGE5 | |
| Interaction | EN1 interactions | 1.81e-05 | 110 | 207 | 8 | int:EN1 | |
| Interaction | SOX7 interactions | 2.16e-05 | 82 | 207 | 7 | int:SOX7 | |
| Interaction | LHX3 interactions | 2.23e-05 | 185 | 207 | 10 | int:LHX3 | |
| Interaction | BAG2 interactions | NCOA6 METTL3 ZNF609 MAPT CUL7 NPHP4 BAP1 PIK3C2A KCNQ2 PHF12 KIAA1671 TRIM33 YEATS2 VPS13D LATS2 MDC1 CDC5L SRRM2 SPEN | 2.42e-05 | 622 | 207 | 19 | int:BAG2 |
| Interaction | DBN1 interactions | MAPT SYNPO NPHP4 BAP1 PIK3C2A ZC3H4 SVIL CGN DNMBP NIPBL SORBS2 INF2 PLEKHG3 HASPIN LIMCH1 | 2.86e-05 | 417 | 207 | 15 | int:DBN1 |
| Interaction | DUXB interactions | 2.96e-05 | 18 | 207 | 4 | int:DUXB | |
| Interaction | SCAI interactions | 3.45e-05 | 60 | 207 | 6 | int:SCAI | |
| Interaction | NUP35 interactions | NCOA6 ZNF609 CUL7 PRR12 ARID1B PIK3C2A CRTC3 ARHGEF19 ATP13A1 PUM2 RBM20 TRIM33 YEATS2 ANKRD17 ZFR | 3.47e-05 | 424 | 207 | 15 | int:NUP35 |
| Interaction | KLF5 interactions | NCOA6 ZNF609 BCL7B BAP1 PRR12 ARID1B NIPBL EP400 PHF12 RBM20 | 3.51e-05 | 195 | 207 | 10 | int:KLF5 |
| Interaction | KCTD13 interactions | TRIO MAPT SYNPO ITPKB SYNJ1 HECW2 SVIL FBXO41 KMT2A KCNQ2 DLAT KIF2A BSN MTUS2 CACNA1A SORBS2 ARHGAP23 ITSN1 APC DHX57 SHROOM2 MADD INF2 TJP1 EIF4G1 SLC4A10 LIMCH1 RIMS1 MARK2 CDC5L CEP170B | 3.86e-05 | 1394 | 207 | 31 | int:KCTD13 |
| Interaction | IQGAP1 interactions | MAPT SYNPO CUL7 BAP1 PIK3C2A SVIL CGN SORBS2 DSCAM APC TRIOBP TRIM33 INF2 PLEKHG3 EIF4G1 LIMCH1 CDC5L SRRM2 | 4.14e-05 | 591 | 207 | 18 | int:IQGAP1 |
| Interaction | TNIK interactions | TRIO MAPT ZNF462 ZC3H4 KCNQ2 KIF2A CACNA1A SORBS2 APC SHISA7 TJP1 RIMS1 CDC5L CEP170B | 4.22e-05 | 381 | 207 | 14 | int:TNIK |
| Interaction | RIMS1 interactions | 5.35e-05 | 40 | 207 | 5 | int:RIMS1 | |
| Interaction | PNMA2 interactions | EMILIN3 CUL7 NPHP4 KIF2A ARHGAP23 EML3 TRIM33 LATS2 HASPIN CEP131 CEP170B | 6.02e-05 | 251 | 207 | 11 | int:PNMA2 |
| Interaction | EZR interactions | MAPT CUL7 BAP1 SYNJ1 SVIL ITSN1 PARG APC TRIOBP C6orf132 KIAA1671 TRIM33 YEATS2 TJP1 DYNC1LI1 LIMCH1 MARK2 | 6.08e-05 | 553 | 207 | 17 | int:EZR |
| Interaction | PACSIN3 interactions | 6.36e-05 | 131 | 207 | 8 | int:PACSIN3 | |
| Interaction | CTNNA1 interactions | MAPT PCP2 CUL7 CGN PKD1 SORBS2 ARHGAP23 APC KIAA1671 TRIM33 TJP1 CEP131 CDC5L | 6.54e-05 | 347 | 207 | 13 | int:CTNNA1 |
| Interaction | CAPZB interactions | MAPT SYNPO CUL7 BAP1 PIK3C2A HECW2 SVIL DLAT KIF2A DNMBP NIPBL TBC1D15 SMTN KIAA1671 INF2 BAZ2A TJP1 MDC1 EIF4G1 HASPIN DYNC1LI1 ANKRD17 MARK2 CDC5L FYB1 | 7.93e-05 | 1049 | 207 | 25 | int:CAPZB |
| Interaction | CIT interactions | ZC3H13 BCL7B SYNPO POGZ ADGRV1 CUL7 CACTIN HECW2 SVIL KMT2A KIF2A HERC1 UHRF2 NIPBL SORBS2 EP400 DSCAM DHX57 C6orf132 KIAA1671 LATS2 INF2 TJP1 MDC1 EIF4G1 HASPIN SLC4A10 ZFR CDC5L SRRM2 CUX1 | 8.04e-05 | 1450 | 207 | 31 | int:CIT |
| Interaction | CSNK2B interactions | POGZ CUL7 BAP1 CACTIN ZC3H4 KMT2A NPAS2 CACNA1A RPS6KA4 EP400 DSCAM ITSN1 PHRF1 APC MADD PHC2 TJP1 CDC5L | 8.47e-05 | 625 | 207 | 18 | int:CSNK2B |
| Interaction | TLX1 interactions | 8.47e-05 | 175 | 207 | 9 | int:TLX1 | |
| Interaction | VIM interactions | METTL3 MAPT NPHP4 BAP1 PLEKHG1 SYNJ1 PIK3C2A SVIL PKD1 UHRF2 DNMBP DSCAM ADNP2 TRIOBP KIAA1671 VPS13D TJP1 EIF4G1 CEP131 CDC5L SRRM2 | 8.70e-05 | 804 | 207 | 21 | int:VIM |
| Interaction | NIN interactions | TCP10L TRIO PLEKHG1 SVIL TTC28 APC KIAA1671 TRIM33 LATS2 TJP1 DYNC1LI1 CEP131 CEP170B | 9.20e-05 | 359 | 207 | 13 | int:NIN |
| Interaction | NTN5 interactions | 9.78e-05 | 24 | 207 | 4 | int:NTN5 | |
| Interaction | ERG interactions | NCOA6 ZNF609 BCL7B PRR12 ARID1B NIPBL TRIM33 ZFHX4 RERE CDC5L | 1.08e-04 | 223 | 207 | 10 | int:ERG |
| Interaction | H2BC21 interactions | POGZ CUL7 PRR12 ARID1B KIAA1549L ZC3H4 SVIL NABP2 KMT2A NIPBL EP400 PHF12 PHC2 YEATS2 LATS2 PHF3 MDC1 SRRM2 FYB1 | 1.08e-04 | 696 | 207 | 19 | int:H2BC21 |
| Interaction | GOLGA1 interactions | PLEKHG1 OSBPL11 DNMBP TTC28 APC EML3 KIAA1671 CEP131 CEP170B | 1.19e-04 | 183 | 207 | 9 | int:GOLGA1 |
| Interaction | GUSBP5 interactions | 1.22e-04 | 75 | 207 | 6 | int:GUSBP5 | |
| Interaction | SPTBN1 interactions | SYNPO NPHP4 BAP1 SPDL1 SVIL KCNQ2 KIF2A DSCAM ITSN1 APC DHX57 HASPIN CDC5L SRRM2 | 1.22e-04 | 421 | 207 | 14 | int:SPTBN1 |
| Interaction | CEP89 interactions | 1.42e-04 | 147 | 207 | 8 | int:CEP89 | |
| Interaction | TLE3 interactions | ZNF609 BAP1 PRR12 CACTIN ARID1B KMT2A NIPBL CRTC3 RBM20 RERE SRRM2 SPEN CUX1 | 1.46e-04 | 376 | 207 | 13 | int:TLE3 |
| Interaction | HNF1B interactions | 1.58e-04 | 190 | 207 | 9 | int:HNF1B | |
| Interaction | KLF8 interactions | ZNF609 POGZ BAP1 PRR12 NIPBL EP400 PHF12 INO80 TRIM33 YEATS2 EIF4G1 SPEN | 1.60e-04 | 329 | 207 | 12 | int:KLF8 |
| Interaction | TBR1 interactions | 1.68e-04 | 113 | 207 | 7 | int:TBR1 | |
| Interaction | NPHP4 interactions | NPHP4 PLEKHG1 EXOC3L4 PKD1 CCDC140 EP400 EML3 SMTN YEATS2 VPS13D | 1.71e-04 | 236 | 207 | 10 | int:NPHP4 |
| Interaction | CCDC6 interactions | TCP10L BAP1 SYNJ1 DNMBP MTUS2 TTC28 ITSN1 APC KIAA1671 CEP170B ZNF445 | 1.90e-04 | 286 | 207 | 11 | int:CCDC6 |
| Interaction | TJP2 interactions | SPDL1 SVIL CGN DNMBP TTC28 APC KIAA1671 LATS2 TJP1 LIMCH1 SRRM2 | 2.02e-04 | 288 | 207 | 11 | int:TJP2 |
| Interaction | NUP50 interactions | BCL7B ZC3H4 KMT2A ARHGEF19 TRIM33 YEATS2 BAZ2A EIF4G1 ZFR SRRM2 SPEN CUX1 | 2.23e-04 | 341 | 207 | 12 | int:NUP50 |
| Interaction | SAA1 interactions | 2.29e-04 | 54 | 207 | 5 | int:SAA1 | |
| Interaction | PHF21A interactions | BAP1 SYNJ1 SFMBT1 TBC1D15 TTC28 PHF12 APC RBM20 KIAA1671 YEATS2 ZFHX4 CEP131 | 2.35e-04 | 343 | 207 | 12 | int:PHF21A |
| Interaction | VASP interactions | SYNJ1 SVIL DNMBP PCARE C6orf132 KIAA1671 INF2 TJP1 LIMCH1 FYB1 CEP170B | 2.42e-04 | 294 | 207 | 11 | int:VASP |
| Interaction | ACTN4 interactions | SYNPO CUL7 BAP1 PIK3C2A SVIL SORBS2 DSCAM INO80 TRIM33 TJP1 HASPIN DYNC1LI1 USP6NL | 2.66e-04 | 400 | 207 | 13 | int:ACTN4 |
| Interaction | TPX2 interactions | 2.69e-04 | 204 | 207 | 9 | int:TPX2 | |
| Interaction | BICD1 interactions | GGA3 PLEKHG1 SYNJ1 DNMBP DSCAM TTC28 KIAA1671 TJP1 DYNC1LI1 CEP170B | 2.72e-04 | 250 | 207 | 10 | int:BICD1 |
| Interaction | GSC interactions | 2.76e-04 | 87 | 207 | 6 | int:GSC | |
| Interaction | ACTC1 interactions | METTL3 MAPT NPHP4 BAP1 SPDL1 CACTIN ARID1B SYNJ1 ZC3H4 WIPF1 EP400 YEATS2 INF2 PHF3 MDC1 ZFR CDC5L SRRM2 | 3.07e-04 | 694 | 207 | 18 | int:ACTC1 |
| Interaction | NCKAP5 interactions | 3.10e-04 | 32 | 207 | 4 | int:NCKAP5 | |
| Interaction | AGAP2 interactions | 3.33e-04 | 210 | 207 | 9 | int:AGAP2 | |
| Interaction | GSN interactions | SYNPO CUL7 NPHP4 BAP1 PLEKHG1 PIK3C2A ARHGAP23 TEX14 PLEKHG3 | 3.57e-04 | 212 | 207 | 9 | int:GSN |
| Interaction | ERLEC1 interactions | 3.61e-04 | 128 | 207 | 7 | int:ERLEC1 | |
| Interaction | PPP1CB interactions | MAPT SYNPO BAP1 PIK3C2A SVIL SORBS2 TRIOBP KIAA1671 INF2 TJP1 PLEKHG3 EIF4G1 DYNC1LI1 LIMCH1 | 3.68e-04 | 469 | 207 | 14 | int:PPP1CB |
| Interaction | AMOT interactions | BAP1 PLEKHG1 PIK3C2A HECW2 CGN DNMBP APC KIAA1671 LATS2 TJP1 CEP131 | 4.00e-04 | 312 | 207 | 11 | int:AMOT |
| Interaction | H3C1 interactions | MAPT POGZ SPDL1 EZHIP CACTIN ZC3H4 KMT2A MLLT3 UHRF2 NIPBL SFMBT1 GRIP1 TRIM33 BAZ2A PHF3 MDC1 EIF4G1 HASPIN ZFR SPEN CUX1 | 4.09e-04 | 901 | 207 | 21 | int:H3C1 |
| Interaction | SH3KBP1 interactions | TCP10L SYNPO SYNJ1 DNMBP PSRC1 RPS6KA4 WIPF1 ITSN1 MDC1 LIMCH1 SRRM2 | 4.34e-04 | 315 | 207 | 11 | int:SH3KBP1 |
| Interaction | SOX17 interactions | 4.44e-04 | 95 | 207 | 6 | int:SOX17 | |
| Interaction | SIPA1L1 interactions | 4.47e-04 | 174 | 207 | 8 | int:SIPA1L1 | |
| Interaction | FMR1 interactions | MAPT BCL7B KIF2A BSN NIPBL APC PUM2 DHX57 TJP1 EIF4G1 ANKRD17 ZFR CDC5L CEP170B CUX1 | 4.50e-04 | 536 | 207 | 15 | int:FMR1 |
| Interaction | KALRN interactions | 4.70e-04 | 96 | 207 | 6 | int:KALRN | |
| Interaction | LIMA1 interactions | SYNPO CUL7 NPHP4 FAM53C BAP1 PIK3C2A SVIL CGN SORBS2 INF2 PLEKHG3 HASPIN SH3RF3 | 5.17e-04 | 429 | 207 | 13 | int:LIMA1 |
| Interaction | CEP135 interactions | XKR4 PLEKHG1 CGN APC KIAA1671 GRIP1 TJP1 CEP131 ULK2 CEP170B | 5.29e-04 | 272 | 207 | 10 | int:CEP135 |
| Interaction | DLGAP1 interactions | 5.60e-04 | 180 | 207 | 8 | int:DLGAP1 | |
| Interaction | XRCC6 interactions | NCOA6 METTL3 CUL7 BAP1 SPDL1 CACTIN ZC3H4 SLX4IP KMT2A DLAT UHRF2 RPS6KA4 EP400 PHRF1 BAZ2A PHF3 MDC1 DYNC1LI1 ZFR SRRM2 SPEN | 6.00e-04 | 928 | 207 | 21 | int:XRCC6 |
| Interaction | SBSPON interactions | 6.21e-04 | 4 | 207 | 2 | int:SBSPON | |
| GeneFamily | PHD finger proteins | 4.70e-06 | 90 | 134 | 7 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.35e-06 | 66 | 134 | 6 | 722 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.48e-05 | 53 | 134 | 5 | 532 | |
| GeneFamily | CTAGE family | 1.70e-04 | 15 | 134 | 3 | 907 | |
| GeneFamily | Super elongation complex|YEATS domain containing | 3.24e-04 | 4 | 134 | 2 | 1283 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.72e-04 | 206 | 134 | 7 | 682 | |
| GeneFamily | PDZ domain containing | 9.49e-04 | 152 | 134 | 6 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.28e-03 | 161 | 134 | 6 | 593 | |
| GeneFamily | Shisa family members | 1.48e-03 | 8 | 134 | 2 | 742 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.38e-03 | 36 | 134 | 3 | 823 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | TCERG1L EMILIN3 KCNH6 BMP2 FBXO41 FGF3 KCNQ2 BSN DSCAM GRIN2C SHISA7 GRIP1 FOXD3 SKOR1 NRG3 IGSF21 SH3RF3 | 1.36e-07 | 438 | 214 | 17 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | TCERG1L EMILIN3 KCNH6 BMP2 FBXO41 FGF3 KCNQ2 BSN DSCAM GRIN2C SHISA7 GRIP1 FOXD3 SKOR1 NRG3 IGSF21 SH3RF3 | 1.45e-07 | 440 | 214 | 17 | MM832 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | PIK3C2A HECW2 SVIL ADGRF5 HERC1 SORBS2 TTC28 TJP1 LIMCH1 NRG3 | 1.98e-07 | 137 | 214 | 10 | M39241 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | AHI1-DT UBE4B MAPT ZC3H13 NCKAP5 ADGRV1 RIN2 SORBS2 WIPF1 ITSN1 KIAA1671 BAZ2A MARK2 SRRM2 CUX1 | 1.94e-06 | 417 | 214 | 15 | M39224 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TCERG1L SPEG XKR4 ZNF462 KIAA1549L SYNJ1 GPR158 CGN MLLT3 HERC1 BSN MTUS2 ADGRL3 CACNA1A DSCAM ARHGAP23 APC IRX3 SHROOM2 TTLL7 GRIP1 ANKRD44 SPINT2 ZFHX4 RIMS1 | 4.39e-06 | 1106 | 214 | 25 | M39071 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MAPT SPEG SYNPO ITPKB PLEKHG1 HECW2 RIN2 ADGRF5 ADGRL3 SFMBT1 TRIB2 ITSN1 PUM2 SHROOM2 ZNRF2 TTLL7 LATS2 INF2 KANK4 ZFR ULK2 | 7.66e-06 | 854 | 214 | 21 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MAPT SPEG SYNPO ITPKB PLEKHG1 HECW2 RIN2 ADGRF5 ADGRL3 SFMBT1 TRIB2 ITSN1 PUM2 SHROOM2 ZNRF2 TTLL7 LATS2 INF2 KANK4 ZFR ULK2 | 1.38e-05 | 888 | 214 | 21 | MM1018 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.52e-05 | 176 | 214 | 9 | M39223 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | TCERG1L EMILIN3 GFI1 NKX2-8 FGF3 KCNQ2 BSN DSCAM DOK7 GRIN2C FOXD3 PRSS50 SKOR1 NRG3 IGSF21 TNXB | 3.11e-05 | 591 | 214 | 16 | M2019 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TRIO MAPT SPEG SYNPO PLEKHG1 TTBK1 SVIL MLLT3 RECK ADGRL3 PCDHGC4 DSCAM ARHGAP23 CCDC28A SHROOM2 ANKRD44 LATS2 ZFR LTBP1 ULK2 RUBCN USP6NL ZNF445 | 3.79e-05 | 1102 | 214 | 23 | M2369 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | TCERG1L EMILIN3 GFI1 NKX2-8 FGF3 KCNQ2 BSN DSCAM DOK7 GRIN2C FOXD3 PRSS50 SKOR1 NRG3 IGSF21 TNXB | 3.80e-05 | 601 | 214 | 16 | MM866 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRIO PTPN4 PIK3C2A ZC3H4 RIN2 KIF2A DNMBP NIPBL SFMBT1 TTC28 ITSN1 PARG APC PUM2 TRIM33 PHF3 ANKRD17 SPEN CUX1 | 8.34e-05 | 856 | 214 | 19 | M4500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | NCKAP5 SYNPO FAM53C ZNF462 TMEM132C BMP2 ZC3H4 HECW2 MLLT3 COL14A1 ADGRL3 CACNA1B TBC1D15 C9orf40 WIPF1 PUM2 ANKRD6 RBM20 ANKRD44 YEATS2 ZFHX4 LTBP1 LIMCH1 RIMS1 CUX1 | 1.09e-06 | 850 | 209 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | MAPT PIK3C2A KCNQ2 COL14A1 KIF2A DNMBP ADGRL3 CACNA1B TTC28 APC ANKRD6 ZFHX4 PHF3 EIF4G1 LTBP1 CUX1 | 3.96e-06 | 416 | 209 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.36e-06 | 134 | 209 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | ZC3H13 CNTN6 PLEKHG1 EXOC3L4 ADGRF5 HERC6 ADGRL3 SFMBT1 WIPF1 AKNA IRX3 ANKRD6 C4orf54 RBM20 TTLL7 BCL6B LATS2 ZFHX4 KANK4 LTBP1 LIMCH1 FYB1 CUX1 | 1.29e-05 | 855 | 209 | 23 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | MIER3 NCKAP5 ZNF462 TMEM132C BMP2 GRHL1 HECW2 MLLT3 COL14A1 ADGRL3 CACNA1B TBC1D15 WIPF1 PUM2 ANKRD6 RBM20 ANKRD44 ZFHX4 ZFR LTBP1 LIMCH1 CUX1 | 2.81e-05 | 836 | 209 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | ZNF609 ZC3H13 POGZ ADGRV1 NPHP4 GGA3 SPDL1 ZNF462 PTPN4 KIAA1549L SYNJ1 MLLT3 KIF2A HERC6 NIPBL PSRC1 CACNA1A PHF12 APC TRIOBP SHISA2 SHROOM2 SHISA7 PHC2 PHF3 ZFR RIMS1 RERE NRG3 CUX1 | 3.20e-05 | 1370 | 209 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | PIK3C2A COL14A1 KIF2A DNMBP ADGRL3 TTC28 APC PHF3 EIF4G1 CUX1 | 4.43e-05 | 209 | 209 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MAPT EMILIN3 ZNF462 TMEM132C PIK3C2A KCNQ2 COL14A1 KIF2A DNMBP ADGRL3 SFMBT1 CACNA1B TTC28 APC PUM2 ANKRD6 ZFHX4 PHF3 EIF4G1 LTBP1 CUX1 | 6.13e-05 | 818 | 209 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | ZNF462 TMEM132C HECW2 MLLT3 COL14A1 ADGRL3 WIPF1 ANKRD6 ANKRD44 ZFHX4 LTBP1 LIMCH1 RIMS1 CUX1 | 9.34e-05 | 428 | 209 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | ZNF462 TMEM132C MLLT3 ADGRL3 WIPF1 ANKRD6 RBM20 ANKRD44 ZFHX4 LIMCH1 | 9.51e-05 | 229 | 209 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | ZNF462 TMEM132C BMP2 HECW2 MLLT3 COL14A1 ADGRL3 PUM2 ANKRD6 ANKRD44 ZFHX4 LTBP1 LIMCH1 CUX1 | 9.57e-05 | 429 | 209 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.17e-04 | 149 | 209 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | EMILIN3 PIK3C2A COL14A1 KIF2A DNMBP ADGRL3 SFMBT1 TTC28 APC PUM2 PHF3 EIF4G1 CUX1 | 1.22e-04 | 385 | 209 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SYNPO ZNF462 TMEM132C PLEKHG1 MLLT3 ADGRL3 CACNA1B SORBS2 APC IRX3 ANKRD6 C6orf132 LATS2 ZFHX4 PHF3 LTBP1 LIMCH1 RIMS1 CUX1 | 2.26e-04 | 769 | 209 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | GRHL1 PIK3C2A COL14A1 ADGRF5 NPAS2 CACNA1B TBC1D15 SORBS2 APC INO80 C4orf54 C6orf132 TTLL7 SMTN LATS2 ZFHX4 RIMS1 TNXB CUX1 | 2.38e-04 | 772 | 209 | 19 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | EMILIN3 NCKAP5 SYNPO ADGRV1 BMP2 PTPN4 KIAA1549L CGN COL14A1 ADGRL3 CACNA1B ARHGEF19 SORBS2 SHISA2 ANKRD44 SPINT2 ZFHX4 PLEKHG3 PODN NRG3 FYB1 CEP170B | 2.52e-04 | 973 | 209 | 22 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | EMILIN3 SYNPO KIAA1549L HECW2 SVIL MLLT3 COL14A1 RECK ADGRL3 CACNA1A TTC28 IRX3 MADD ANKRD44 VPS13D ZFHX4 PRICKLE3 KANK4 NRG3 FYB1 ULK2 CEP170B | 2.52e-04 | 973 | 209 | 22 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | NCKAP5 FAM53C ZC3H4 HECW2 ADGRL3 TBC1D15 C9orf40 WIPF1 PUM2 RBM20 ANKRD44 YEATS2 ZFHX4 LTBP1 | 2.92e-04 | 478 | 209 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 3.11e-04 | 217 | 209 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | NCKAP5 SYNPO PLEKHG1 BMP2 HECW2 RIN2 ADGRF5 CX3CL1 SHROOM2 BCL6B NRG3 SH3RF3 | 1.78e-10 | 190 | 217 | 12 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | XKR4 SYNJ1 GPR158 FBXO41 HERC1 BSN CX3CL1 CACNA1B MADD ZFR NRG3 CEP170B | 2.27e-10 | 194 | 217 | 12 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | XKR4 KIAA1549L GPR158 HECW2 HERC1 MTUS2 CACNA1B SORBS2 GRIP1 SLC4A10 RIMS1 NRG3 | 2.87e-10 | 198 | 217 | 12 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | XKR4 KIAA1549L HECW2 PKD1 HERC1 MTUS2 CACNA1A CACNA1B SORBS2 SLC4A10 RIMS1 NRG3 | 3.22e-10 | 200 | 217 | 12 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PLEKHG1 HECW2 RIN2 ADGRF5 CX3CL1 ADGRL3 SHROOM2 KIAA1671 BCL6B NRG3 SH3RF3 | 2.46e-09 | 189 | 217 | 11 | b6b4da51bc7f2c13a2f940540fdc61027d084835 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAPT ZNF462 PLEKHG1 BMP2 HECW2 ADGRF5 TTC28 ARHGAP23 TTLL7 TJP1 PCDHGC3 | 3.07e-09 | 193 | 217 | 11 | 826b8dd801298b3e0cd76232feae5a14026b8806 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAPT ZNF462 PLEKHG1 BMP2 HECW2 ADGRF5 TTC28 ARHGAP23 TTLL7 TJP1 PCDHGC3 | 3.07e-09 | 193 | 217 | 11 | 87d3a577d37fb0cb4b6313c596310de452bc3872 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SYNJ1 KMT2A HERC1 CACNA1A TTC28 GRIN2C MADD TTLL7 ZFR RERE SRRM2 | 3.42e-09 | 195 | 217 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | XKR4 KIAA1549L GPR158 MTUS2 CACNA1A CACNA1B SORBS2 GRIP1 SLC4A10 RIMS1 NRG3 | 4.01e-09 | 198 | 217 | 11 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | PLEKHG1 HECW2 RIN2 CX3CL1 ADGRL3 SHROOM2 KIAA1671 BCL6B NRG3 SH3RF3 | 2.07e-08 | 180 | 217 | 10 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | SPEG SVIL COL14A1 MTUS2 ADGRL3 RBM20 TTLL7 SMTN LTBP1 SH3RF3 | 2.07e-08 | 180 | 217 | 10 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | NCKAP5 SYNPO PLEKHG1 HECW2 ADGRF5 CX3CL1 SHROOM2 BCL6B NRG3 SH3RF3 | 3.29e-08 | 189 | 217 | 10 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | GPR158 FBXO41 KMT2A KCNQ2 BSN RAB26 CACNA1B GRIP1 SLC4A10 NRG3 | 3.45e-08 | 190 | 217 | 10 | 416de85d8841dac883faa6f5339b2fb461a09e82 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.63e-08 | 191 | 217 | 10 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PLEKHG1 HECW2 RIN2 ADGRF5 CX3CL1 ADGRL3 KIAA1671 BCL6B NRG3 SH3RF3 | 3.63e-08 | 191 | 217 | 10 | 1de0bdfd13bd930691564c2673f2e66393bc0255 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | ZNF609 TRIO NCKAP5 ARID1B SVIL SORBS2 TTC28 ANKRD17 RERE CUX1 | 3.81e-08 | 192 | 217 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAPT PLEKHG1 BMP2 HECW2 ADGRF5 TTC28 ARHGAP23 TTLL7 TJP1 PCDHGC3 | 4.00e-08 | 193 | 217 | 10 | d485634c564b268e344b6a2863c26f6adaec9e38 |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | NCKAP5 PLEKHG1 HECW2 ADGRF5 CX3CL1 ADGRL3 ARHGAP23 BCL6B NRG3 SH3RF3 | 4.00e-08 | 193 | 217 | 10 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-08 | 195 | 217 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | XKR4 KIAA1549L GPR158 PKD1 MTUS2 CACNA1B SORBS2 SLC4A10 RIMS1 NRG3 | 4.63e-08 | 196 | 217 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | XKR4 KIAA1549L GPR158 MTUS2 CACNA1A CACNA1B SORBS2 SLC4A10 RIMS1 NRG3 | 5.10e-08 | 198 | 217 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-07 | 173 | 217 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-07 | 176 | 217 | 9 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-07 | 180 | 217 | 9 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-07 | 180 | 217 | 9 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.74e-07 | 181 | 217 | 9 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | NCKAP5 PLEKHG1 HECW2 ADGRF5 CX3CL1 ADGRL3 SHROOM2 NRG3 SH3RF3 | 2.74e-07 | 181 | 217 | 9 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-07 | 184 | 217 | 9 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-07 | 184 | 217 | 9 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | NCKAP5 PLEKHG1 GRHL1 MLLT3 CX3CL1 ARHGAP23 GRIP1 LTBP1 RIMS1 | 3.30e-07 | 185 | 217 | 9 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.45e-07 | 186 | 217 | 9 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.61e-07 | 187 | 217 | 9 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | TMEM132C PLEKHG1 PIK3C2A RIN2 ADGRF5 SHROOM2 KIAA1671 NRG3 SH3RF3 | 3.95e-07 | 189 | 217 | 9 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 4.51e-07 | 192 | 217 | 9 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.71e-07 | 193 | 217 | 9 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-07 | 193 | 217 | 9 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-07 | 193 | 217 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-07 | 193 | 217 | 9 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.36e-07 | 196 | 217 | 9 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.59e-07 | 197 | 217 | 9 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.83e-07 | 198 | 217 | 9 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | KIAA1549L PKD1 MTUS2 CACNA1A CACNA1B SORBS2 SLC4A10 RIMS1 NRG3 | 5.83e-07 | 198 | 217 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.08e-07 | 199 | 217 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 159 | 217 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | TCERG1L CATSPERD CNTN6 TMEM132C ADGRL3 CACNA1A DSCAM SLC4A10 | 1.41e-06 | 163 | 217 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 167 | 217 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-06 | 167 | 217 | 8 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-06 | 167 | 217 | 8 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 169 | 217 | 8 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.93e-06 | 170 | 217 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-06 | 170 | 217 | 8 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-06 | 170 | 217 | 8 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-06 | 170 | 217 | 8 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-06 | 184 | 217 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 3.47e-06 | 184 | 217 | 8 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 186 | 217 | 8 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.76e-06 | 186 | 217 | 8 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 3.92e-06 | 187 | 217 | 8 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.92e-06 | 187 | 217 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.92e-06 | 187 | 217 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.07e-06 | 188 | 217 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.07e-06 | 188 | 217 | 8 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.40e-06 | 190 | 217 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 4.40e-06 | 190 | 217 | 8 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 191 | 217 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.58e-06 | 191 | 217 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 4.76e-06 | 192 | 217 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.76e-06 | 192 | 217 | 8 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 4.94e-06 | 193 | 217 | 8 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.94e-06 | 193 | 217 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-06 | 193 | 217 | 8 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.94e-06 | 193 | 217 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-06 | 194 | 217 | 8 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.13e-06 | 194 | 217 | 8 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.13e-06 | 194 | 217 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.13e-06 | 194 | 217 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.13e-06 | 194 | 217 | 8 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 5.23e-06 | 138 | 217 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 196 | 217 | 8 | a5cc4f76e1a3825aaccba9a686d7da6f7e4300ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 196 | 217 | 8 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-06 | 196 | 217 | 8 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 196 | 217 | 8 | 476812fc1422aca8010d771eff11fa6081f15a2d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 196 | 217 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.53e-06 | 196 | 217 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-06 | 196 | 217 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 5.53e-06 | 196 | 217 | 8 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 5.53e-06 | 196 | 217 | 8 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.75e-06 | 197 | 217 | 8 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-06 | 197 | 217 | 8 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.75e-06 | 197 | 217 | 8 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 5.96e-06 | 198 | 217 | 8 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-06 | 198 | 217 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-06 | 198 | 217 | 8 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.96e-06 | 198 | 217 | 8 | c7075dce915ab8387309fcb12c5f6a17d4100cda | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-06 | 198 | 217 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.19e-06 | 199 | 217 | 8 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-06 | 200 | 217 | 8 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | ZNF609 SPEG POGZ KIAA1549L MLLT3 SHROOM2 VPS13D INF2 ZFR MARK2 CDC5L SRRM2 | 3.18e-07 | 200 | 207 | 12 | 5853_DN |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | ZNF609 TRIO PTPN4 NIPBL NPAS2 ITSN1 DTL TRIM33 YEATS2 ZFHX4 ANKRD17 | 4.99e-07 | 171 | 207 | 11 | 7535_DN |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | ITPKB CACTIN HERC6 C9orf40 DSCAM ITSN1 APC EML3 SMTN TRIM33 BAZ2A | 2.22e-06 | 199 | 207 | 11 | 2754_DN |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | MAPT GFI1 CACTIN SYNJ1 COL14A1 WIPF1 APC PLEKHG3 CHRD LIMCH1 RERE | 2.22e-06 | 199 | 207 | 11 | 3570_UP |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.59e-06 | 174 | 207 | 10 | 7530_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | SYNJ1 ZC3H4 OSBPL11 KIF2A NIPBL ADNP2 PUM2 TRIM33 SPEN USP6NL | 6.83e-06 | 182 | 207 | 10 | 3887_DN |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 9.09e-06 | 188 | 207 | 10 | 2053_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 9.09e-06 | 188 | 207 | 10 | 4845_DN | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | UBE4B SYNPO SVIL PSRC1 TRIB2 SHROOM2 EML3 VPS13D ZFHX4 BAZ2A | 1.14e-05 | 193 | 207 | 10 | 1233_DN |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ZNF609 RIN2 NIPBL ITSN1 TRIOBP SMTN BAZ2A PLEKHG3 LTBP1 RERE | 1.20e-05 | 194 | 207 | 10 | 1480_DN |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | ZNF609 SVIL NABP2 ADGRF5 APC DHX57 PPP4R4 SMTN MARK2 CEP170B | 1.20e-05 | 194 | 207 | 10 | 4291_DN |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | UBE4B ITPKB BMP2 KIAA1549L SVIL KIF2A APC SHROOM2 CEP131 CDC5L | 1.31e-05 | 196 | 207 | 10 | 2099_DN |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | STIM1 KCNH6 CACTIN KIAA1549L HERC6 ANKRD6 TTLL7 BAZ2A PLEKHG3 SRRM2 | 1.37e-05 | 197 | 207 | 10 | 7311_UP |
| Drug | genistein; Down 200; 10uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 1235_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | EVPL RPS6KA4 C9orf40 EP400 EML3 SMTN TRIM33 INF2 PRICKLE3 PHF3 | 1.43e-05 | 198 | 207 | 10 | 5334_DN |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A | UBE4B MAPT KIF2A RAB26 SORBS2 TTLL7 VPS13D PLEKHG3 RERE FYB1 | 1.43e-05 | 198 | 207 | 10 | 4661_DN |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A | METTL3 UBE4B SPEG STIM1 CACTIN KIAA1549L MLLT3 VPS13D CDC5L SRRM2 | 1.43e-05 | 198 | 207 | 10 | 2085_DN |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 3757_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 4592_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | 1.49e-05 | 199 | 207 | 10 | 5844_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | SPEG FBXO41 COL14A1 RAB26 SORBS2 APC PPP4R4 MADD TRIM33 PLEKHG3 | 1.49e-05 | 199 | 207 | 10 | 5048_UP |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | UBE4B HERC6 ADGRL3 CACNA1A APC NRG2 ANKRD6 PPP4R4 PHF3 USP6NL | 1.49e-05 | 199 | 207 | 10 | 2725_DN |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.49e-05 | 199 | 207 | 10 | 5769_DN | |
| Drug | LY294002; Up 200; 10uM; HL60; HG-U133A | ZC3H13 SYNPO KMT2A RAB26 RECK CACNA1A TRIB2 TRIM33 VPS13D MARK2 | 1.56e-05 | 200 | 207 | 10 | 361_UP |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.65e-05 | 177 | 207 | 9 | 4652_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.17e-05 | 180 | 207 | 9 | 4541_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 4.35e-05 | 181 | 207 | 9 | 1791_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.09e-05 | 189 | 207 | 9 | 1045_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 1670_DN | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 6835_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 2993_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 1163_DN | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 5744_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 2440_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 2056_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 2818_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 4808_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 6335_DN | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 5014_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; HL60; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 2188_UP | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7372_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 4568_DN | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; MCF7; HG-U133A | 8.70e-05 | 198 | 207 | 9 | 575_DN | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 6275_UP | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 5476_DN | |
| Drug | cyclosporine A; Down 200; 1uM; MCF7; HG-U133A | 8.70e-05 | 198 | 207 | 9 | 602_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 4093_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 6332_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 3756_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 2855_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 4526_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 7271_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 7384_UP | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A | 9.04e-05 | 199 | 207 | 9 | 2046_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 5488_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 6992_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 5512_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.32e-04 | 178 | 207 | 8 | 5086_DN | |
| Drug | Chloroprene | TRIO ZC3H13 POGZ ZNF462 TMEM132C PTPN4 GRHL1 ARID1B EXOC3L4 MLLT3 CX3CL1 PSRC1 TBX1 ADGRL3 NPAS2 SHISA2 SHROOM2 TTLL7 BCL6B ZFHX4 EIF4G1 KANK4 LIMCH1 SRRM2 FYB1 ZNF445 | 2.40e-04 | 1348 | 207 | 26 | ctd:D002737 |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.51e-04 | 180 | 207 | 8 | 7094_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.70e-04 | 182 | 207 | 8 | 1951_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 3.01e-04 | 185 | 207 | 8 | 1114_DN | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 3.13e-04 | 186 | 207 | 8 | 3819_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.48e-04 | 189 | 207 | 8 | 2790_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.61e-04 | 190 | 207 | 8 | 2619_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA | 3.73e-04 | 191 | 207 | 8 | 994_UP | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; PC3; HT_HG-U133A | 3.73e-04 | 191 | 207 | 8 | 4563_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.73e-04 | 191 | 207 | 8 | 1059_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; HL60; HT_HG-U133A | 3.87e-04 | 192 | 207 | 8 | 2183_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 3.87e-04 | 192 | 207 | 8 | 458_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.87e-04 | 192 | 207 | 8 | 7427_DN | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 2482_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 6981_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 5839_DN | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 2894_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 1830_UP | |
| Drug | loperamide | 4.00e-04 | 105 | 207 | 6 | CID000003954 | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 4.14e-04 | 194 | 207 | 8 | 1060_UP | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 5418_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 4727_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 4284_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 5826_DN | |
| Drug | 5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA | 4.14e-04 | 194 | 207 | 8 | 843_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 4662_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 3812_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 1264_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 1296_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 6338_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 7264_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 4692_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 4817_UP | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 5070_DN | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 5329_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 5330_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 2748_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 3503_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | 4.29e-04 | 195 | 207 | 8 | 6626_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 207 | 8 | 5293_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 207 | 8 | 5230_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 207 | 8 | 7259_DN | |
| Disease | Neurodevelopmental Disorders | 3.49e-07 | 93 | 210 | 8 | C1535926 | |
| Disease | platelet component distribution width | STIM1 EXOC3L4 RIN2 SVIL MLLT3 ADGRF5 KIF2A HERC1 NPAS2 WIPF1 C4orf54 BCL6B TRIM33 SPINT2 BAZ2A PLEKHG3 FYB1 TNXB CUX1 | 2.21e-06 | 755 | 210 | 19 | EFO_0007984 |
| Disease | epilepsy (implicated_via_orthology) | 2.74e-06 | 163 | 210 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | interleukin-6 measurement, response to cytokine | 5.04e-05 | 2 | 210 | 2 | EFO_0004810, GO_0034097 | |
| Disease | interleukin-6 measurement, response to corticosteroid, response to cytokine | 5.04e-05 | 2 | 210 | 2 | EFO_0004810, GO_0031960, GO_0034097 | |
| Disease | cortical surface area measurement | MAPT ZC3H13 NCKAP5 ADGRV1 PLEKHG1 BMP2 ARID1B PKD1 MLLT3 CACNA1A APC TRIOBP PHC2 GRIP1 SPINT2 TJP1 MDC1 SLC4A10 RERE CDC5L SH3RF3 TNXB CUX1 | 9.67e-05 | 1345 | 210 | 23 | EFO_0010736 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.51e-04 | 3 | 210 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 3.00e-04 | 4 | 210 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Central Nervous System Neoplasms | 3.00e-04 | 4 | 210 | 2 | C0085136 | |
| Disease | serum gamma-glutamyl transferase measurement | PLB1 BCL7B EXOC3L4 SVIL PKD1 KMT2A MLLT3 DNMBP PSRC1 ARHGEF19 SORBS2 TRIOBP ZNRF2 LBHD2 TJP1 IGSF21 USP6NL | 3.15e-04 | 914 | 210 | 17 | EFO_0004532 |
| Disease | atrial fibrillation | 3.51e-04 | 371 | 210 | 10 | EFO_0000275 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 4.97e-04 | 5 | 210 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | blood osmolality measurement | 7.83e-04 | 58 | 210 | 4 | EFO_0007967 | |
| Disease | Paroxysmal atrial fibrillation | 9.07e-04 | 156 | 210 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 9.07e-04 | 156 | 210 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.07e-04 | 156 | 210 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 1.03e-03 | 160 | 210 | 6 | C0004238 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.03e-03 | 7 | 210 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | cognitive function measurement, self reported educational attainment | 1.06e-03 | 355 | 210 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | cup-to-disc ratio measurement | BMP2 KIAA1549L KMT2A TRIB2 TTC28 TRIOBP PLEKHG3 RERE MARK2 CUX1 | 1.09e-03 | 430 | 210 | 10 | EFO_0006939 |
| Disease | estradiol measurement | 1.16e-03 | 110 | 210 | 5 | EFO_0004697 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.25e-03 | 30 | 210 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.37e-03 | 8 | 210 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Cornelia De Lange Syndrome | 1.37e-03 | 8 | 210 | 2 | C0270972 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.51e-03 | 32 | 210 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | lean body mass | 1.66e-03 | 379 | 210 | 9 | EFO_0004995 | |
| Disease | red blood cell density measurement | MAPT ADGRV1 ZNF462 ARID1B ZC3H4 ADGRF5 KIF2A UHRF2 TRIB2 EP400 ITSN1 INO80 PHC2 TRIM33 FYB1 | 1.68e-03 | 880 | 210 | 15 | EFO_0007978 |
| Disease | chronotype measurement | RGSL1 MAPT ITPKB ZNF462 HECW2 BSN ADGRL3 NPAS2 TTC28 TEX14 MADD TRIM33 RIMS1 RERE CUX1 | 1.72e-03 | 882 | 210 | 15 | EFO_0008328 |
| Disease | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 1.76e-03 | 9 | 210 | 2 | C4049702 | |
| Disease | velocardiofacial syndrome (implicated_via_orthology) | 1.76e-03 | 9 | 210 | 2 | DOID:12583 (implicated_via_orthology) | |
| Disease | gastritis | 1.76e-03 | 9 | 210 | 2 | EFO_0000217 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.81e-03 | 34 | 210 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.81e-03 | 34 | 210 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.81e-03 | 34 | 210 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.81e-03 | 34 | 210 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.81e-03 | 34 | 210 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.81e-03 | 34 | 210 | 3 | C0087012 | |
| Disease | Malignant neoplasm of breast | NCOA6 CNTN6 BAP1 GGA3 BMP2 ARID1B OSBPL11 FGF3 NIPBL ZNF541 SHROOM2 MOSPD1 PRICKLE3 FCRL5 CYB5R4 SPEN CUX1 | 1.85e-03 | 1074 | 210 | 17 | C0006142 |
| Disease | Spinocerebellar Ataxia Type 4 | 1.97e-03 | 35 | 210 | 3 | C0752122 | |
| Disease | cholesteryl ester 16:0 measurement | 2.13e-03 | 36 | 210 | 3 | EFO_0010341 | |
| Disease | long QT syndrome (implicated_via_orthology) | 2.18e-03 | 10 | 210 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | POGZ PLEKHG1 ARID1B TTBK1 KIAA1549L PIK3C2A PKD1 SLX4IP FGF3 NPAS2 WIPF1 DSCAM TTC28 TRIOBP INO80 MADD PHC2 LATS2 ZFHX4 LTBP1 | 2.34e-03 | 1392 | 210 | 20 | EFO_0005763 |
| Disease | hematocrit | MAPT SYNPO ADGRV1 STIM1 ZNF462 PRR12 PLEKHG1 ARID1B ZC3H4 SLX4IP MLLT3 BSN UHRF2 TRIB2 ANKRD17 CDC5L | 2.51e-03 | 1011 | 210 | 16 | EFO_0004348 |
| Disease | late onset Parkinson's disease (is_implicated_in) | 2.66e-03 | 11 | 210 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | meningitis | 2.66e-03 | 11 | 210 | 2 | MONDO_0021108 | |
| Disease | triacylglycerol 56:2 measurement | 2.66e-03 | 11 | 210 | 2 | EFO_0010429 | |
| Disease | nucleus accumbens volume change measurement | 2.66e-03 | 11 | 210 | 2 | EFO_0021493 | |
| Disease | chronic kidney disease, Proteinuria | 2.66e-03 | 11 | 210 | 2 | EFO_0003884, HP_0000093 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.10e-03 | 41 | 210 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.10e-03 | 41 | 210 | 3 | C0858252 | |
| Disease | Methionine sulfoxide measurement | 3.17e-03 | 12 | 210 | 2 | EFO_0021650 | |
| Disease | cancer (implicated_via_orthology) | 3.20e-03 | 268 | 210 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | SPEG MIER3 EMILIN3 ARID1B SVIL SLX4IP NPAS2 DOK7 ANKRD6 KIAA1671 TRIM33 CUX1 | 3.24e-03 | 670 | 210 | 12 | EFO_0006335, EFO_0006336 |
| Disease | age at assessment, pelvic organ prolapse | 3.56e-03 | 43 | 210 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | cognitive impairment measurement | 3.80e-03 | 44 | 210 | 3 | EFO_0007998 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.88e-03 | 145 | 210 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Disorder of eye | 4.23e-03 | 212 | 210 | 6 | C0015397 | |
| Disease | ventricular septal defect (is_implicated_in) | 4.34e-03 | 14 | 210 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.34e-03 | 14 | 210 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.34e-03 | 14 | 210 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Schizophrenia | AHI1-DT KCNH6 KMT2A KCNQ2 KIF2A TBX1 NPAS2 CACNA1B ADNP2 APC GRIN2C MARK2 NRG3 TNXB | 4.52e-03 | 883 | 210 | 14 | C0036341 |
| Disease | Salivary Gland Neoplasms | 4.58e-03 | 47 | 210 | 3 | C0036095 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.73e-03 | 152 | 210 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | smoking status measurement, carotid artery intima media thickness | 4.86e-03 | 48 | 210 | 3 | EFO_0006527, EFO_0007117 | |
| Disease | prostate carcinoma | TRIO EVC CNTN6 SPDL1 EZHIP GRHL1 BSN TBX1 TTC28 IRX3 SHROOM2 YEATS2 SPINT2 SPEN | 4.89e-03 | 891 | 210 | 14 | EFO_0001663 |
| Disease | severe acute respiratory syndrome, COVID-19 | CATSPERD MAPT CNTN6 TMEM132C PTPN4 OSBPL11 ADGRL3 GRIP1 SLC4A10 | 4.95e-03 | 447 | 210 | 9 | EFO_0000694, MONDO_0100096 |
| Disease | Down syndrome (implicated_via_orthology) | 4.98e-03 | 15 | 210 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.98e-03 | 15 | 210 | 2 | C3645536 | |
| Disease | anemia (implicated_via_orthology) | 4.98e-03 | 15 | 210 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | worry measurement | 5.00e-03 | 154 | 210 | 5 | EFO_0009589 | |
| Disease | urate measurement, bone density | PLB1 UBE4B ITPKB DSCAM TTC28 PARG GRIN2C LATS2 CYB5R4 SH3RF3 TNXB | 5.03e-03 | 619 | 210 | 11 | EFO_0003923, EFO_0004531 |
| Disease | daytime rest measurement | 5.38e-03 | 295 | 210 | 7 | EFO_0007828 | |
| Disease | QRS amplitude, QRS complex | 5.45e-03 | 50 | 210 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | cortical thickness | MAPT NCKAP5 ADGRV1 ZNF462 PLEKHG1 BMP2 ARID1B PKD1 KMT2A TRIOBP GRIP1 VPS13D RERE CDC5L ULK2 SH3RF3 | 6.26e-03 | 1113 | 210 | 16 | EFO_0004840 |
| Disease | dermatomyositis (is_marker_for) | 6.39e-03 | 17 | 210 | 2 | DOID:10223 (is_marker_for) | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 6.39e-03 | 17 | 210 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.39e-03 | 17 | 210 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | ischemia (implicated_via_orthology) | 6.39e-03 | 17 | 210 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 6.75e-03 | 54 | 210 | 3 | C0278883 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPSSGLTAASRDQVP | 96 | Q6ZRM9 | |
| RASSRSFTQAIPAGQ | 36 | Q6ZS92 | |
| RPRGNNLSTISDTSP | 2106 | O00555 | |
| EPQTPAQGSRRTSSR | 21 | Q17RC7 | |
| AAPFQTSQASASAPR | 1521 | Q96L91 | |
| NTVLSTPFRTPSNGA | 406 | Q99459 | |
| QFRASATARAGTEPP | 771 | Q86XM0 | |
| SNSERLSGPAEPRSF | 631 | Q8IX94 | |
| SNSERLSGPAEPRSF | 631 | P0CG41 | |
| SNSERLSGPAEPRSF | 631 | A4FU28 | |
| PGTANSRQFSLPVVS | 41 | A6NCI8 | |
| NQTSPRSAATGLPIS | 6 | P29965 | |
| SQPRAERSQLQGPSS | 861 | P39880 | |
| RQPSSPSHNTNLRAG | 131 | Q9UIF9 | |
| SFTPSQTRQQGPLRS | 391 | P42568 | |
| PRDSPTLSNSGIRAT | 896 | Q9HD20 | |
| RRNPASAATPSTAVG | 91 | Q7Z4H9 | |
| RRNPASAATPSAAVG | 86 | B1ANY3 | |
| GRRNRSTSTPSPAVE | 461 | Q9HAR2 | |
| NSDFSTGQPSVRRPG | 3881 | Q8WXG9 | |
| SAFNSPLRSPIRSAN | 501 | Q92560 | |
| EHGSSSPRFPRQNSG | 1366 | Q6XZF7 | |
| SRAPSPASFQRSLEN | 1621 | Q8NFD5 | |
| RPAGADTRSSANQLP | 86 | P0C7V0 | |
| DTRSSANQLPQPSGA | 91 | P0C7V0 | |
| SPRSPSSQTPNSRRQ | 676 | Q9NZJ0 | |
| NGSPSSPSVRRQLFV | 1986 | O75179 | |
| AANTATTTGPRQPFS | 1221 | Q9Y4F5 | |
| RKFAAASSGRPSSQP | 31 | P12643 | |
| KSNSSAAREPNGFPS | 61 | Q9BQE9 | |
| RASPESAQSTDPGRA | 106 | Q96MF4 | |
| SAQSTDPGRAARPRT | 111 | Q96MF4 | |
| AQTSLPAFSPGRLSR | 2216 | Q00975 | |
| SGPTRHRAQQPAASS | 626 | Q9Y2G4 | |
| PVRPGASQNTTFLTS | 581 | Q6IQ32 | |
| SAQPEQGRPATRSTF | 871 | Q5JR59 | |
| AASTLPTANGARPAR | 16 | Q9ULW5 | |
| TSDRTPPSFGGRLNN | 356 | Q5T481 | |
| QDPTALGFRRNSSPQ | 116 | Q8IVA1 | |
| QAIFRTDSSPGPSQI | 166 | O95980 | |
| DFNRTPGSRQASPTE | 171 | Q8TB72 | |
| RSPPGTPNHRNSTFT | 391 | P29074 | |
| APQSRATNSPASITG | 1391 | Q9ULG1 | |
| PPRRVSSLSESSGLQ | 806 | Q99743 | |
| PRANLSPSSSFRAQR | 331 | Q8IW93 | |
| NGASSLRSRNSPGPL | 291 | O75106 | |
| SPQNSPGTQRANARA | 1171 | Q9P2P5 | |
| RASPRSTTARNTAAP | 176 | P56975 | |
| TTNRALTNSPGEPAT | 10806 | Q8WXI7 | |
| SSNNLSRVPAGLPRS | 296 | Q7Z5L7 | |
| REPPSPQGRSSNSSE | 926 | Q8WXG6 | |
| PEPTSQATRGRTNRS | 1426 | Q14676 | |
| PLSRATNGPSDSQAR | 886 | Q9BY89 | |
| NVPAPSRADSTSNAG | 31 | Q99684 | |
| LGSRSQVFASDSPPQ | 331 | Q9NRM7 | |
| QPNAGRSVALPASSA | 1181 | Q5T848 | |
| SERLAFQSRSGSPDP | 376 | Q86X51 | |
| TVSSTPGARRQPSAE | 136 | P11487 | |
| SQSARPANRTALSDP | 2726 | Q15751 | |
| GPNTPSSAVSRLAQA | 71 | Q9H252 | |
| SRQAETARATSVPGP | 276 | Q9UPA5 | |
| SPSSRQIPSGAASRQ | 3761 | Q9UPA5 | |
| GFSNPASQSTSQRPK | 126 | Q8IWP9 | |
| GEDFPASPQRRNTAS | 201 | Q9Y6G9 | |
| PENSASAQSPRFSRQ | 416 | A6NNH2 | |
| RPVLRASSFQPISGN | 191 | Q96RD9 | |
| GSPQAQTVRRSPSAD | 456 | O43526 | |
| SGPPRSRTFNVALNA | 46 | Q14766 | |
| SRSGPAPARRNSVTT | 36 | P10515 | |
| TSRSSTRGSLNPENP | 626 | O00443 | |
| TSPAASDARSFPSRQ | 21 | Q86W56 | |
| RSSARSPGSIFQPQL | 321 | Q14999 | |
| SLRPSQQAPSGSDLA | 506 | Q92817 | |
| SNSTREPPASGRVAL | 146 | O14511 | |
| VNSRPFRVTGPNSSS | 16 | O15117 | |
| FPSQASPQRVRSLEG | 166 | Q8IVU3 | |
| PSSRFVPPQTSSGNR | 151 | Q6KC79 | |
| SFQPENRAVSSGPSL | 146 | Q9UJG1 | |
| ASATFQTTPGPQASR | 66 | Q13670 | |
| AAPVSFQRNSGSLSR | 536 | Q9P1Y6 | |
| QASGPPRSRSSSQAE | 361 | Q9NZ52 | |
| PRSRSSSQAEATLGP | 366 | Q9NZ52 | |
| SRISGQDSPPRVSAS | 646 | A8MYU2 | |
| YRSRQSLNSPSPGET | 1471 | Q6ZVL6 | |
| RGPSQSRAAAAPSPS | 66 | A0A0U1RRK4 | |
| RSATASRRGSPAPAN | 736 | O75676 | |
| VDENASRSNGPRSTP | 971 | Q8N8A2 | |
| STSNSQRLPRPQGAA | 256 | Q6PGN9 | |
| GTVNASALTSNRPEP | 366 | Q7Z3K6 | |
| SSQRPSARPASPGSD | 66 | O15522 | |
| PGAASPLASRQNTLR | 776 | Q9UN70 | |
| QARDRGNPPLSSTVT | 536 | Q9Y5F7 | |
| GPQARREASSSSPEA | 31 | Q86U28 | |
| SEQPRANSLGPSDRT | 11 | C9JSJ3 | |
| FSSNQPPAAGSSRQD | 1116 | Q27J81 | |
| RNPEAALSPTFRSDS | 36 | Q86U44 | |
| TLPPSRSRVISNDGA | 841 | O75161 | |
| PGSLSQTRHSRPAQA | 2441 | Q7Z442 | |
| SPPADTSFSSRRGRQ | 1256 | Q86UR5 | |
| NALSSSPAPNIQTGR | 1716 | Q14686 | |
| LLTNSPGSSGNRRSP | 1796 | Q14686 | |
| PDDSAFGRQSTPRVS | 461 | O43900 | |
| ARARPSQFPEQSSSA | 116 | O00139 | |
| SPSEATRLPTQGARS | 736 | Q5T0Z8 | |
| TRLPTQGARSSAAFP | 741 | Q5T0Z8 | |
| SAPTFLRQGPRASAA | 1356 | Q711Q0 | |
| ASSGPLQDSRPFRSL | 201 | Q96ID5 | |
| SSGAQAPNAQRRTPD | 196 | Q9NZI5 | |
| GPQSRLSPTAATVQF | 251 | Q8N143 | |
| AQDTSGSPSERARPL | 281 | Q8N143 | |
| PRAGAANSQLSTSQP | 46 | Q96C57 | |
| PGRLNQTTFTATRPG | 176 | P00403 | |
| NPSLSTTNLSGPSRR | 371 | Q6UUV7 | |
| SPPRNLRISNVGSNS | 536 | Q05707 | |
| IFSESRRPSRPSNSN | 66 | Q6P158 | |
| VPSAGQLRQRSAFTP | 881 | Q15811 | |
| SSPSGPLRQRAPNFS | 996 | Q7Z591 | |
| EPQLAPRGTSLQSFS | 801 | Q9UQ52 | |
| AVSSSRNPNSAGRTP | 56 | P0C7T7 | |
| AQPPSSAASRVQSAA | 56 | Q04637 | |
| SAASRVQSAAPARPG | 61 | Q04637 | |
| AANGGSERSQPPRSS | 446 | Q8TF61 | |
| PPQDRRRFFNSSGSS | 36 | Q8TF76 | |
| RRFSDQAAGPAIPTS | 406 | Q7KZI7 | |
| APDRTNFPRGVSSRS | 581 | Q7KZI7 | |
| PLGNAPQASTSRSEV | 111 | Q5T7N3 | |
| ARLESTPNSRFSAPS | 441 | Q03164 | |
| GSSPTNKTARNVPFS | 571 | Q9ULL0 | |
| PGRSQSPRAAAAALS | 121 | Q8WUQ7 | |
| PQRADTPRRNSSSSS | 146 | Q32P44 | |
| DSASPGRSARPLVQT | 491 | Q9NT22 | |
| SNAQTPSETGSPSRR | 71 | P57679 | |
| PSASPSKRRDSGDNS | 66 | Q8IXQ3 | |
| SASTSQEGPRPAAAQ | 291 | Q18PE1 | |
| PTSNNPRGALTTTEF | 91 | A6NH13 | |
| RSPSFQPDVASSRDG | 116 | P54792 | |
| APTPRSQLGRQASFQ | 941 | Q9Y3R0 | |
| SPTSSDLARPNAGRS | 446 | D6RIA3 | |
| SLGPQASRFLPSARS | 236 | Q9NYF3 | |
| SVPNNGSERRSTSFP | 236 | Q92622 | |
| DQPRGFTLPSNARSS | 131 | Q9UPN4 | |
| NARSSSALDSPAGPR | 141 | Q9UPN4 | |
| RRAGSQSPARAPSTS | 216 | Q8NCU7 | |
| STAQSFLRPPGTVQS | 411 | Q9UJU5 | |
| DSFGSRSRQTPSPDV | 206 | Q9UPQ0 | |
| NRPSGIPERFSGSNS | 71 | A0A075B6K5 | |
| SAQFEAATSPSPRRV | 2076 | P98161 | |
| PSGQNRTSESSLARP | 966 | A6NGG8 | |
| SPISQRRPSQNAISF | 181 | Q9BXB4 | |
| GDPSRPKNATRESTS | 126 | P78415 | |
| VSDARPGTNPTTRRN | 1721 | O60469 | |
| RSISQPSPANTDRGE | 826 | P84550 | |
| GRSAPPSTNVRSADQ | 841 | A5PLK6 | |
| ANANRGPTSPSVTAI | 651 | Q9UPN9 | |
| TRNHSGSRTPPVALN | 2096 | Q9UQ35 | |
| SSRTPQAPASANLVG | 2326 | Q9UQ35 | |
| QPRSPVPSAFSDQSR | 2446 | Q9UQ35 | |
| DFTGAQRTQPTESPR | 516 | Q8IWB6 | |
| RTRNASSVPSSFSPN | 821 | Q6NUP7 | |
| QAASRSPSFGDPQLS | 256 | O95425 | |
| RLGPSPRNRSSSLFN | 366 | Q8N3T6 | |
| TRTNPFSDRTAAPGN | 1401 | O43426 | |
| TLLGQRSSSNNSAPP | 151 | Q8TDR4 | |
| QTPGSRSRPAIESSD | 891 | O14513 | |
| FFNPSAVSQRTTSPG | 1016 | A1L390 | |
| IAAQLTTPPSSNSRG | 156 | Q8N3V7 | |
| TTPPSSNSRGVQLFN | 161 | Q8N3V7 | |
| PRPSFSTRNAGIEAQ | 906 | Q8N3V7 | |
| AQSSAIQAPRSPRLG | 156 | P27987 | |
| RASRGQPRTVPVSSN | 691 | Q7Z3K3 | |
| NQRFSSPAPSSDGKV | 686 | Q96QT6 | |
| SERSGNTPNSPRLAA | 546 | Q96EA4 | |
| SFQNDSPPQVRGLSS | 451 | Q13796 | |
| ANSGARAPPTRSQTN | 191 | Q6UWI4 | |
| QARARPSNATSAEPA | 16 | A6NL88 | |
| VRRPASASASEGNPF | 796 | Q5T8A7 | |
| PINEDIRSSGRNSPS | 601 | Q9P2R6 | |
| RESPFSGSSRQPDSL | 1136 | Q9BZV3 | |
| TAVGARPNNSSDLPT | 1106 | Q6P1J6 | |
| QPGPSASSLLSQFRS | 101 | Q9ULL5 | |
| SQSFPAPRSQQRVAS | 6 | Q7L1T6 | |
| QLPTAPARRQDSSGS | 16 | E7EW31 | |
| TPSPVGDSRALQASR | 626 | Q13586 | |
| DQSASRTSPGRVDLP | 271 | O94875 | |
| GPRADSSQRAPSLLT | 181 | Q9H2D6 | |
| GPRSTTSQASPAQRD | 251 | Q9H2D6 | |
| NPRASSPSRATRDNP | 486 | Q9H2D6 | |
| IARRRNDGQASSSPP | 201 | Q5VYV7 | |
| RFSQALQSGDSPPLS | 831 | Q8IZF2 | |
| RRDAAASASTPAQAP | 41 | P55789 | |
| RSGSRDSTPSRPAQQ | 2301 | P25054 | |
| PAQSQNLSPLSGFSR | 251 | Q9P2M7 | |
| PQERSSSERQPSGLS | 126 | Q9H2X0 | |
| DSTARGNRPVASTPV | 326 | Q5VWI1 | |
| GPSNQPSTSARARLI | 106 | Q96PU4 | |
| PSTRTPNANGTERTR | 291 | Q8WYP3 | |
| ASGARAAQSPFSIPN | 91 | Q8NHG8 | |
| TLRTQQTPAAAASGP | 226 | Q8IXK0 | |
| LFQASARRAASPPSS | 3481 | Q86UP3 | |
| SNGQRSVGRPSPLAS | 386 | Q92738 | |
| RSPRLPASTSAARNA | 1231 | Q5TCY1 | |
| QRLASQASRPTRSPS | 256 | Q96T58 | |
| SRPQTPLSEASGRLS | 371 | Q15772 | |
| KPSPSQNRRSSDTGS | 851 | Q15772 | |
| GSLDLNFTSPSRQAP | 796 | Q8TEJ3 | |
| TSRNAADSSVPSAPR | 101 | O43291 | |
| RSAEPSQSFSPNLGS | 31 | Q92519 | |
| TGSLQSQPPRRSAAS | 1471 | Q9P227 | |
| QAVPASSSRQRPSST | 361 | O95155 | |
| GRESPSFDTPSQRVQ | 86 | Q6U841 | |
| STRITRSQPNHTPAG | 176 | Q9BQ15 | |
| ARAGPFSSRSNVTLP | 21 | P22105 | |
| RGSQNSSEHRPPASS | 411 | O15014 | |
| EARPSTPQRQASNAS | 206 | Q5GH76 | |
| DPRQAAGRSQPVTTS | 1651 | Q92576 | |
| QDGRPPQTAAREATS | 241 | P10636 | |
| SRNGSTSRALPATPQ | 386 | O43516 | |
| LSASGARNDSPTQIP | 666 | Q8TC07 | |
| PNARQRPGASTDSST | 1021 | Q9UPT8 | |
| SGQRARHNSFTSPSP | 91 | Q6ZRN7 | |
| SRHSPQQPSNGSLRS | 326 | Q07157 | |
| SRSRNSSGSPVPQAQ | 501 | Q8IYT8 | |
| VSPTQDGTSSLPRRQ | 1371 | Q96AY4 | |
| SSASSPQSPGDALRR | 956 | Q96KR1 | |
| AAQAERSPPARSSSQ | 921 | P59923 | |
| RNNSRVSPVPLSGAA | 2166 | Q96JM2 | |
| QFDRQAPGRISTSPT | 36 | Q6ZR37 | |
| RSSASVDNTPAGSPQ | 681 | Q9UHJ3 | |
| AASTSRPLETQGNPT | 146 | Q5PR19 | |
| SSARPSPAQRNSQPS | 501 | Q9ULL1 | |
| SAFARSRNPVASPTQ | 316 | O43435 | |
| RSAGLQSPNSPRCFS | 361 | Q53SZ7 | |
| QTVARGQRPRTSAPS | 6 | Q9UI38 | |
| NRESTPLASGPSSFQ | 311 | P53814 | |
| QSPSSGDTRPFSAQQ | 611 | Q6ZT98 | |
| PQTGTPRTTAVSSNR | 96 | Q8N7P7 | |
| PRTTAVSSNRNPGDD | 101 | Q8N7P7 | |
| PQTGTPRTTAVSSNR | 266 | Q8N7P7 | |
| SQSGSSIQRHSPSPR | 336 | Q5T200 | |
| TFPGDSDSLQRQTPR | 2501 | O75962 | |
| RSSSPANQRAETPSA | 121 | Q9ULM3 | |
| TPSSQEAQRALGTSP | 141 | P78423 | |
| LFRGQTVPASSQPSS | 396 | Q9H0D2 | |
| PTGSLRDSRAQSPVS | 1031 | Q5THJ4 | |
| RDSRAQSPVSGPNVA | 1036 | Q5THJ4 | |
| FSSSGPPQAQFRARL | 36 | Q14957 |